https://curecurrent.com/trials/performance-of-inherited-risk-assessment-for-predicting-prostate-cancer-from-prostate-biopsy-56001https://curecurrent.com/trials/single-patient-compassionate-use-of-x-pact-in-salvage-treatment-of-prostate-cancer-56002https://curecurrent.com/trials/study-to-evaluate-the-clinical-impact-of-a-laparoscopic-radical-prostatectomy-simulator-56003https://curecurrent.com/trials/detecting-clinically-significant-prostate-cancer-with-advanced-mri-protocols-and-extensive-histopathology-56004https://curecurrent.com/trials/the-impact-of-force-feedback-in-the-dv5-robotic-surgical-system-on-learning-curve-and-safety-in-robot-assisted-radical-p-56005https://curecurrent.com/trials/focal-laser-ablation-of-prostate-cancer-a-feasibility-study-using-mri-us-image-fusion-for-guidance-56006https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicines-called-enzalutamide-and-abiraterone-in-people-with-metastatic-castration-resi-56007https://curecurrent.com/trials/proton-based-stereotactic-ablative-body-radiotherapy-for-prostate-cancer-56008https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-localized-high-risk-prostate-cancer-56009https://curecurrent.com/trials/imaagen-impact-of-abiraterone-acetate-in-prostate-specific-antigen-56010https://curecurrent.com/trials/177lupsma-in-renal-cell-carcinoma-56011https://curecurrent.com/trials/efficacy-evaluation-of-focused-hifu-high-intensity-focused-ultrasound-therapy-in-patients-with-localized-intermediate-ri-56012https://curecurrent.com/trials/revelution-2-relugolix-abiraterone-acetate-aa-versus-leuprolide-aa-cardiac-trial-56013https://curecurrent.com/trials/cognitive-effects-of-androgen-receptor-directed-therapies-for-advanced-prostate-cancer-56014https://curecurrent.com/trials/evolution-of-lesions-in-repeated-biparametric-prostate-magnetic-resonance-imaging-56015https://curecurrent.com/trials/study-of-azd0754-in-participants-with-metastatic-prostate-cancer-56016https://curecurrent.com/trials/evaluation-of-the-impact-of-empty-versus-full-bladder-in-patients-with-prostate-cancer-relief-trial-56017https://curecurrent.com/trials/stereotactic-ablative-radiotherapy-sabr-of-pelvis-and-prostate-targets-for-high-risk-prostate-cancer-56018https://curecurrent.com/trials/randomized-mri-guided-prostate-boosts-via-initial-lattice-stereotactic-vs-daily-moderately-hypofractionated-radiotherapy-56019https://curecurrent.com/trials/a-phase-iii-study-of-radium-223-dichloride-in-patients-with-symptomatic-hormone-refractory-prostate-cancer-with-skeletal-56020https://curecurrent.com/trials/pre-operative-nurse-led-education-with-direct-physiotherapy-referral-to-reduce-post-prostatectomy-incontinence-56021https://curecurrent.com/trials/gu-01-glycyrrhizin-in-prostate-cancer-56022https://curecurrent.com/trials/cart-psma-tgf-rdn-cells-for-castrate-resistant-prostate-cancer-56023https://curecurrent.com/trials/diagnostic-utility-of-rhpsma-7-3-18f-pet-ct-in-men-with-prostate-cancer-on-active-surveillance-56024https://curecurrent.com/trials/safety-and-activity-study-of-psca-targeted-car-t-cells-bpx-601-in-subjects-with-selected-advanced-solid-tumors-56025https://curecurrent.com/trials/hyperthermia-and-high-dose-rate-radiation-therapy-in-treating-patients-with-recurrent-prostate-cancer-after-radiation-56026https://curecurrent.com/trials/psma-pet-for-treatment-response-evaluation-of-systemic-therapies-in-prostate-cancer-pelican-56027https://curecurrent.com/trials/evaluating-in-vivo-parp-1-expression-with-18f-fluorthanatrace-positron-emission-tomography-pet-ct-in-prostate-cancer-56028https://curecurrent.com/trials/the-present-study-aims-to-compare-patients-who-receive-the-investigational-product-177lu-dota-rosopatamab-plus-standard-56029https://curecurrent.com/trials/phase-ib-iia-dose-escalation-and-expansion-study-of-pb-pb-advc001-in-metastatic-prostate-cancer-therapb-phase-i-ii-study-56030https://curecurrent.com/trials/metabolic-impact-of-prospective-controlled-mediterranean-type-diets-on-prostate-cancer-56031https://curecurrent.com/trials/study-of-stm-416p-administered-to-patients-undergoing-radical-prostatectomy-56032https://curecurrent.com/trials/stereotactic-ablative-radiation-therapy-for-prostate-cancer-56033https://curecurrent.com/trials/trial-targeting-gut-bacterial-androgen-production-to-reverse-therapeutic-resistance-to-abiraterone-in-patients-with-meta-56034https://curecurrent.com/trials/targeted-prostate-cancer-screening-in-men-with-brca1-2-mutations-56035https://curecurrent.com/trials/development-of-a-therapeutic-education-program-for-patients-with-metastatic-prostate-cancer-treated-with-new-generation-56036https://curecurrent.com/trials/the-university-of-miami-adapt-uadapt-trial-56037https://curecurrent.com/trials/copper-cu-64-psma-i-t-pet-imaging-in-men-with-suspected-recurrence-of-prostate-cancer-56038https://curecurrent.com/trials/robot-assisted-radical-prostatectomy-the-hood-technique-versus-standard-anterior-reconstruction-56039https://curecurrent.com/trials/hypofractionated-adaptive-image-guided-radiation-therapy-for-localized-adenocarcinoma-of-the-prostate-56040https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-drug-levels-of-asp5541-in-chinese-participants-with-prostate-cancer-56041https://curecurrent.com/trials/sequential-bpmri-for-suspicious-prostate-lesions-56042https://curecurrent.com/trials/image-guided-tumor-focused-radiotherapy-treatment-in-intermediate-and-high-risk-prostate-cancer-56043https://curecurrent.com/trials/a-study-of-jnj-70218902-in-participants-with-advanced-stage-solid-tumors-56044https://curecurrent.com/trials/proton-radiation-therapy-for-the-treatment-of-patients-with-high-risk-prostate-cancer-56045https://curecurrent.com/trials/clinical-trial-to-evaluate-post-operative-outcomes-of-ureteral-stent-vs-ureteral-stent-free-radical-cystectomy-56046https://curecurrent.com/trials/buffered-lidocaine-for-reducing-pain-in-patients-undergoing-prostate-biopsy-burn-trial-56047https://curecurrent.com/trials/metastasis-directed-stereotactic-body-radiotherapy-for-oligo-metastatic-hormone-sensitive-prostate-cancer-56048https://curecurrent.com/trials/a-trial-evaluating-toxicity-of-sbrt-and-ldrb-in-localized-prostate-cancer-56049https://curecurrent.com/trials/comparing-mri-ultrasound-fusion-and-cognitive-guided-biopsy-for-the-detection-of-cspca-the-profusion-trial-56050https://curecurrent.com/trials/evaluation-of-a-postural-rehabilitation-program-based-on-sensory-motor-control-in-men-with-urinary-incontinence-after-pr-56051https://curecurrent.com/trials/fatigue-interventions-in-cancer-exercise-intervention-56052https://curecurrent.com/trials/screening-and-staging-of-benign-vs-malignant-pelvic-abnormalities-56053https://curecurrent.com/trials/observational-study-of-the-effectiveness-of-funded-drugs-for-genitourinary-tumors-56054https://curecurrent.com/trials/efficacy-and-safety-of-vasoclip-vs-weckclip-for-robotic-urologic-surgery-56055https://curecurrent.com/trials/psma-pet-for-surveillance-after-focal-therapy-56056https://curecurrent.com/trials/clinical-and-molecular-correlates-of-positron-emission-tomography-pet-with-89zr-dfo-huj591-in-metastatic-prostate-cancer-56057https://curecurrent.com/trials/image-guided-focal-brachytherapy-utilizing-combined-18f-dcfpyl-pet-ct-56058https://curecurrent.com/trials/using-breath-cell-free-dna-and-image-analysis-to-predict-normal-tissue-and-tumour-response-during-prostate-cancer-sbrt-56059https://curecurrent.com/trials/androgen-receptor-signaling-and-prostate-specific-membrane-antigen-expression-56060https://curecurrent.com/trials/salvage-radiotherapy-combined-with-hormonotherapy-in-oligometastatic-pelvic-node-relapses-of-prostate-cancer-56061https://curecurrent.com/trials/improving-engagement-from-underserved-communities-with-prostate-cancer-genetics-services-56062https://curecurrent.com/trials/dual-psma-and-fdg-pet-imaging-for-patients-with-advanced-prostate-cancer-56063https://curecurrent.com/trials/image-guided-68ga-psma-11-pet-ct-prostate-biopsy-for-the-diagnosis-of-prostate-cancer-in-men-with-prior-negative-inconcl-56064https://curecurrent.com/trials/relugolix-versus-leuprolide-cardiac-trial-56065https://curecurrent.com/trials/ablative-radiotherapy-for-unfavorable-prostate-tumors-2-0-56066https://curecurrent.com/trials/mr-us-image-fusion-targeted-biopsy-for-single-cell-prostate-cancer-research-56067https://curecurrent.com/trials/search-for-predictive-factors-of-resistance-to-treatment-for-metastatic-castration-resistant-prostate-cancer-by-studying-56068https://curecurrent.com/trials/enfortumab-vedotin-as-monotherapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-56069https://curecurrent.com/trials/assessing-radio-hybrid-prostate-specific-membrane-antigen-rhpsma-7-3-18f-in-healthy-volunteers-and-subjects-with-prostat-56070https://curecurrent.com/trials/radiation-and-androgen-ablation-for-prostate-cancer-56071https://curecurrent.com/trials/coaction-trial-combination-androgen-blockade-in-intermediate-to-high-risk-prostate-cancer-56072https://curecurrent.com/trials/a-study-of-a-pelvic-floor-muscle-exercise-program-before-and-after-radical-prostatectomy-56073https://curecurrent.com/trials/prospective-validation-of-pathology-based-artificial-intelligence-diagnostic-model-for-lymph-node-metastasis-in-prostate-56074https://curecurrent.com/trials/continuous-monitoring-of-prostate-position-during-radiotherapy-56075https://curecurrent.com/trials/erdafitinib-for-the-treatment-of-patients-with-castration-resistant-prostate-cancer-56076https://curecurrent.com/trials/focal-radiotherapy-for-previously-treated-prostate-cancer-patients-56077https://curecurrent.com/trials/dose-de-escalation-in-prostate-radiotherapy-using-an-mr-linac-in-two-fractions-56078https://curecurrent.com/trials/bipolar-androgen-therapy-bat-and-radium-223-rad-in-metastatic-castration-resistant-prostate-cancer-mcrpc-56079https://curecurrent.com/trials/a-clinical-study-evaluating-the-benefit-of-adding-rucaparib-to-enzalutamide-for-men-with-metastatic-prostate-cancer-that-56080https://curecurrent.com/trials/neoadjuvant-darolutamide-and-relugolix-combination-preceding-radical-prostatectomy-for-prostate-cancer-56081https://curecurrent.com/trials/antiandrogen-therapy-and-sbrt-in-treating-patients-with-recurrent-metastatic-prostate-cancer-56082https://curecurrent.com/trials/safety-and-efficacy-evaluation-of-lc-k76-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-56083https://curecurrent.com/trials/hypofractionated-wppt-with-hdr-boost-56084https://curecurrent.com/trials/image-guidance-and-online-adaptation-with-stereotactic-body-radiation-therapy-for-the-treatment-of-localized-prostate-ca-56085https://curecurrent.com/trials/pharmaceutical-management-in-targeted-radioligand-therapy-56086https://curecurrent.com/trials/prostate-adaptive-radiation-therapy-56087https://curecurrent.com/trials/fezolinetant-for-treating-hot-flashes-in-men-with-prostate-cancer-56088https://curecurrent.com/trials/safety-and-preliminary-efficacy-evaluation-of-lc-k76-plus-anti-pd-1-therapy-in-patients-with-metastatic-castration-resis-56089https://curecurrent.com/trials/hypofractionated-radiotherapy-with-a-focal-microboost-for-high-risk-and-locally-advanced-prostate-cancer-56090https://curecurrent.com/trials/the-i4i-prodict-study-evaluation-of-the-i4i-prodict-test-in-different-ethnic-groups-the-i4i-prodict-study-56091https://curecurrent.com/trials/micro-ultrasound-for-detecting-clinically-significant-prostate-cancer-in-active-surveillance-56092https://curecurrent.com/trials/the-role-of-18f-psma-pet-in-prostate-cancer-diagnosis-in-equivocal-mri-56093https://curecurrent.com/trials/psma-targeted-intraoperative-fluorescent-imaging-agents-dgpr1008-validation-across-different-time-windows-56094https://curecurrent.com/trials/hcq-in-resectable-localized-prostate-cancer-56095https://curecurrent.com/trials/men-with-prostate-cancer-optimizing-wellness-by-enhanced-relief-from-hot-flashes-with-acupuncture-56096https://curecurrent.com/trials/the-barcode-2-study-the-use-of-genetic-profiling-to-guide-prostate-cancer-treatment-56097https://curecurrent.com/trials/sarcopenia-in-older-patient-with-prostate-cancer-prevalence-and-incidence-after-androgen-deprivation-therapy-56098https://curecurrent.com/trials/a-phase-iii-study-comparing-hrs-4357-with-novel-androgen-receptor-pathway-inhibitors-in-patients-with-progressive-psma-p-56099https://curecurrent.com/trials/exploring-men-s-prostate-cancer-genetic-risk-perceptions-56100https://curecurrent.com/trials/the-active-surveillance-study-56101https://curecurrent.com/trials/a-safety-and-dose-finding-study-of-prl-02-depot-in-men-with-advanced-prostate-cancer-56102https://curecurrent.com/trials/prospective-trial-acute-myocardial-injury-after-radical-prostatectomy-56103https://curecurrent.com/trials/psma-pet-registry-18f-dcfpyl-56104https://curecurrent.com/trials/physician-and-patient-based-barriers-to-ngs-testing-56105https://curecurrent.com/trials/a-platform-study-of-epigenetic-therapy-before-prostatectomy-in-men-with-prostate-cancer-56106https://curecurrent.com/trials/prostate-cancer-research-using-cross-validation-of-innovative-sampling-integrating-lc-ms-ms-for-optimized-therapeutic-dr-56107https://curecurrent.com/trials/multi-omic-approach-to-study-hdr-brachytherapy-for-favorable-risk-and-low-tier-intermediate-risk-prostate-cancer-56108https://curecurrent.com/trials/identification-of-prostate-cancer-specific-markers-in-patients-compared-to-healthy-participants-56109https://curecurrent.com/trials/salvage-ultrahypofractionated-postoperative-external-radiotherapy-for-biochemical-recurrence-56110https://curecurrent.com/trials/prostate-ablation-registry-and-database-for-information-surveillance-and-evaluation-paradise-56111https://curecurrent.com/trials/safety-tolerability-and-preliminary-efficacy-of-161tb-lnc1011-psma-radioligand-in-patients-with-metastatic-castration-re-56112https://curecurrent.com/trials/patient-reported-erectile-recovery-and-quality-of-life-outcomes-with-lyopreserved-placental-tissue-applied-directly-over-56113https://curecurrent.com/trials/clinical-and-dosimetric-study-of-patients-treated-with-177lu-psma-617-for-prostate-cancer-56114https://curecurrent.com/trials/utility-of-dynamic-variables-measured-by-calibrated-pulse-contour-analysis-of-oesophageal-doppler-monitor-for-predicting-56115https://curecurrent.com/trials/assessing-a-digital-exercise-intervention-for-health-outcomes-and-engagement-in-regular-exercise-56116https://curecurrent.com/trials/optimal-prostate-study-56117https://curecurrent.com/trials/development-and-prospective-validation-of-a-pathology-based-artificial-intelligence-model-for-predicting-the-time-to-cas-56118https://curecurrent.com/trials/carboplatin-chemotherapy-before-surgery-for-people-with-high-risk-prostate-cancer-and-an-inherited-brca1-or-brca2-gene-m-56119https://curecurrent.com/trials/ldr-vs-hdr-brachytherapy-for-prostate-cancer-56120https://curecurrent.com/trials/improving-health-literacy-in-african-american-prostate-cancer-patients-56121https://curecurrent.com/trials/pilot-of-18f-dcfpyl-psma-pet-in-mcrpc-patients-receiving-117lu-vipivotide-tetraxetan-56122https://curecurrent.com/trials/real-world-evidence-study-on-metastatic-prostate-cancer-in-the-pirkanmaa-hospital-district-in-finland-56123https://curecurrent.com/trials/the-development-and-validation-of-mri-ai-based-predictive-models-for-cspca-56124https://curecurrent.com/trials/two-fraction-prostate-sbrt-with-dil-sib-56125https://curecurrent.com/trials/the-impact-of-age-and-sex-on-anticipated-and-experienced-pain-in-first-time-outpatient-flexible-cystoscopy-56126https://curecurrent.com/trials/improving-quality-of-life-after-prostate-brachytherapy-a-comparison-of-hdr-and-ldr-brachytherapy-56127https://curecurrent.com/trials/hdr-brachytherapy-ebrt-and-stad-for-the-treatment-of-prostate-cancer-56128https://curecurrent.com/trials/evaluation-of-treatment-response-using-multiparametric-mri-after-prostate-radiotherapy-56129https://curecurrent.com/trials/prct001-aquablation-therapy-outcomes-in-prostate-cancer-patients-56130https://curecurrent.com/trials/talazoparib-with-androgen-deprivation-therapy-and-abiraterone-for-the-treatment-of-castration-sensitive-prostate-cancer-56131https://curecurrent.com/trials/exploiting-heterogeneity-in-hormone-therapy-response-to-reveal-early-determinants-of-drug-resistance-in-advanced-pca-56132https://curecurrent.com/trials/adt-and-sbrt-vs-sbrt-alone-for-unfavorable-intermediate-risk-prostate-cancer-56133https://curecurrent.com/trials/phase-ii-non-randomized-study-evaluating-posluma-psma-pet-response-after-oligo-metastatic-progressive-directed-treatment-56134https://curecurrent.com/trials/gz17-6-02-in-advanced-crpc-after-progression-on-anti-androgen-therapy-56135https://curecurrent.com/trials/lutetium-177-dosimetry-as-a-predictive-biomarker-of-response-in-metastatic-prostate-cancer-patients-treated-with-psma-ra-56136https://curecurrent.com/trials/an-investigational-immunotherapy-study-of-nivolumab-in-combination-with-rucaparib-docetaxel-or-enzalutamide-in-metastati-56137https://curecurrent.com/trials/safety-and-efficacy-study-of-enzalutamide-in-patients-with-nonmetastatic-castration-resistant-prostate-cancer-56138https://curecurrent.com/trials/the-peer-genetic-study-56139https://curecurrent.com/trials/abiraterone-with-discontinuation-of-gonadotropin-releasing-hormone-analogues-in-metastatic-prostate-cancer-56140https://curecurrent.com/trials/study-of-psma-pet-mr-guided-stereotactic-body-radiation-therapy-with-simultaneous-integrated-boost-sbrt-sib-for-high-int-56141https://curecurrent.com/trials/imaging-characteristics-of-different-ga-psma-probes-in-prostate-cancer-56142https://curecurrent.com/trials/sequential-study-of-225ac-lnc1011-in-the-treatment-of-metastatic-castration-resistant-prostate-cancer-56143https://curecurrent.com/trials/health-related-quality-of-life-and-multidimensional-evaluations-of-prostate-cancer-subjects-aged-60-years-initiating-gon-56144https://curecurrent.com/trials/the-value-of-grpr-pet-imaging-for-diagnosis-and-staging-in-prostate-cancer-56145https://curecurrent.com/trials/study-of-allogeneic-anti-psma-car-nk-cell-for-metastatic-castration-resistant-prostate-cancer-56146https://curecurrent.com/trials/smart-prostate-specific-antigen-psa-screening-study-56147https://curecurrent.com/trials/an-exploratory-clinical-study-evaluating-the-safety-and-efficacy-of-allogeneic-car-nk-cell-therapy-for-metastatic-castra-56148https://curecurrent.com/trials/testing-whether-the-addition-of-carboplatin-chemotherapy-to-cabazitaxel-chemotherapy-will-improve-outcomes-compared-to-c-56149https://curecurrent.com/trials/apalutamide-with-or-without-stereotactic-body-radiation-in-treating-castration-resistant-prostate-cancer-56150https://curecurrent.com/trials/prostate-cancer-early-detection-using-serial-mri-examinations-56151https://curecurrent.com/trials/addition-of-focal-boost-to-primary-radiotherapy-for-prostate-cancer-in-12-or-20-fractions-56152https://curecurrent.com/trials/delayed-pelvic-imaging-with-68-ga-psma-pet-ct-in-a-patient-with-high-risk-prostate-cancer-56153https://curecurrent.com/trials/spcg17-prostate-cancer-active-surveillance-trigger-trial-56154https://curecurrent.com/trials/decipher-lethal-prostate-cancer-biology-urine-metabolomics-56155https://curecurrent.com/trials/anxiety-in-patients-under-active-surveillance-for-localized-prostate-cancer-and-their-partners-56156https://curecurrent.com/trials/post-prostatectomy-radiation-therapy-moderate-versus-ultra-hypofractionated-also-known-as-stereotactic-body-radiation-th-56157https://curecurrent.com/trials/a-comparison-of-radical-prostatectomy-and-precision-prostatectomy-in-low-and-intermediate-risk-prostate-cancers-56158https://curecurrent.com/trials/improving-germline-testing-in-at-risk-patients-with-prostate-cancer-56159https://curecurrent.com/trials/the-impact-of-physical-activity-versus-dietary-energy-restriction-on-tumour-and-muscle-protein-synthesis-in-prostate-can-56160https://curecurrent.com/trials/lymphedema-after-urologic-surgery-56161https://curecurrent.com/trials/vitamin-d-for-prostate-endocrine-therapy-56162https://curecurrent.com/trials/focal-radiation-for-oligometastatic-castration-resistant-prostate-cancer-force-56163https://curecurrent.com/trials/a-trial-of-hrs-5041-103-to-evaluate-the-safety-tolerability-pharmacokinetics-and-efficacy-of-hrs-5041-in-subjects-with-m-56164https://curecurrent.com/trials/stereotactic-body-radiation-therapy-or-intensity-modulated-radiation-therapy-in-treating-patients-with-stage-iia-b-prost-56165https://curecurrent.com/trials/a-feasibility-study-evaluating-a-role-for-maintenance-therapy-in-patients-with-biochemically-progressive-castration-sens-56166https://curecurrent.com/trials/adaptive-stereotactic-radiotherapy-for-localized-prostate-cancer-56167https://curecurrent.com/trials/efficacy-of-ra-223-in-psma-pet-optimally-selected-patients-56168https://curecurrent.com/trials/urokinase-plasminogen-activator-receptor-in-abiraterone-treated-patients-with-castration-resistant-prostate-cancer-56169https://curecurrent.com/trials/difluoromethylornithine-and-high-dose-testosterone-with-enzalutamide-in-metastatic-castration-resistant-prostate-cancer-56170https://curecurrent.com/trials/study-evaluating-mcrpc-treatment-using-psma-lu-177-pnt2002-therapy-after-second-line-hormonal-treatment-56171https://curecurrent.com/trials/the-prostate-cancer-genetic-risk-and-equitable-screening-study-progress-56172https://curecurrent.com/trials/a-randomised-trial-of-cabazitaxel-docetaxel-mitoxantrone-or-satraplatin-cdms-plus-surgery-for-prostate-cancer-patients-56173https://curecurrent.com/trials/microarray-analysis-of-gene-expression-in-prostate-tissues-56174https://curecurrent.com/trials/impact-of-radical-prostatectomy-as-primary-treatment-in-patients-with-prostate-cancer-with-limited-bone-metastases-56175https://curecurrent.com/trials/minimal-residual-disease-used-in-predicting-therapeutic-efficacy-in-metastatic-hormone-sensitive-prostate-cancer-56176https://curecurrent.com/trials/o-tadalafil-for-prevention-of-docetaxel-induced-peripheral-neuropathy-in-prostate-cancer-56177https://curecurrent.com/trials/role-of-lymphnode-dissection-in-men-with-prostate-cancer-treated-with-radical-prostatectomy-56178https://curecurrent.com/trials/efficacy-of-the-pelvic-clock-device-for-functional-recovery-after-robotic-assisted-radical-prostatectomy-56179https://curecurrent.com/trials/early-prostate-cancer-recurrence-with-psma-pet-positive-unilateral-pelvic-lesion-s-56180https://curecurrent.com/trials/non-significant-risk-nsr-study-of-68ga-psma-11-illuccix-as-a-bgrt-bioguide-on-reflexion-x1-56181https://curecurrent.com/trials/the-precision-study-3-fractions-of-prostate-sbrt-and-raypilot-hypocath-image-guidance-56182https://curecurrent.com/trials/detection-of-minimal-residual-disease-post-prostatectomy-56183https://curecurrent.com/trials/navigation-outcomes-and-quality-of-life-in-prostate-cancer-patients-undergoing-psma-targeted-surgery-56184https://curecurrent.com/trials/study-of-predicting-lymph-node-metastasis-of-high-risk-prostate-cancer-by-artificial-intelligence-multi-omics-analysis-56185https://curecurrent.com/trials/a-web-based-peer-navigation-program-for-men-with-prostate-cancer-56186https://curecurrent.com/trials/an-investigational-scan-68ga-psma-11-pet-for-the-imaging-of-prostate-cancer-56187https://curecurrent.com/trials/diet-and-physical-activity-intervention-for-the-prevention-of-adt-induced-metabolic-changes-in-patients-with-prostate-ca-56188https://curecurrent.com/trials/tens-for-pain-relief-during-fusion-guided-prostate-biopsy-56189https://curecurrent.com/trials/mri-guided-transurethral-ultrasound-ablation-of-localized-prostate-cancer-56190https://curecurrent.com/trials/combo-of-cabozantinib-with-abiraterone-in-chemotherapy-na-ve-subjects-with-bone-metastatic-crpc-56191https://curecurrent.com/trials/focal-or-radical-therapy-a-lesion-based-molecular-evaluation-in-prostate-cancer-56192https://curecurrent.com/trials/evaluating-treatment-outcomes-using-darolutamide-and-androgen-deprivation-therapy-in-patients-with-metastatic-hormone-se-56193https://curecurrent.com/trials/177lu-htk03170-in-mcrpc-with-psma-positive-disease-56194https://curecurrent.com/trials/prostate-cancer-upgrading-reference-set-56195https://curecurrent.com/trials/adaptive-radiotherapy-for-genitourinary-cancers-56196https://curecurrent.com/trials/a-multicenter-open-label-non-randomized-phase-i-iia-clinical-trial-to-evaluate-inr102-injection-in-patients-with-prostat-56197https://curecurrent.com/trials/magnetic-resonance-mr-imaging-with-hyperpolarized-13c-pyruvate-13c-15n-urea-in-patients-with-prostate-cancer-56198https://curecurrent.com/trials/the-safety-and-tolerability-of-pgv001-based-personalized-multi-peptide-vaccines-in-the-adjuvant-setting-56199https://curecurrent.com/trials/upright-mri-for-prostate-cancer-screening-56200https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-dosimetry-of-68ga-oncoacp3-in-patients-with-prostate-cancer-56201https://curecurrent.com/trials/establishment-and-promotion-of-an-ai-based-early-warning-system-for-prostate-and-bladder-cancer-screening-in-the-male-co-56202https://curecurrent.com/trials/propranolol-combined-with-novel-endocrine-therapy-and-androgen-deprivation-therapy-adt-for-neoadjuvant-treatment-in-high-56203https://curecurrent.com/trials/study-of-re-treatment-with-177lu-lu-psma-in-men-with-metastatic-castration-resistance-prostate-cancer-56204https://curecurrent.com/trials/evaluation-of-neuroendocrine-differentiation-as-a-potential-mechanism-of-tumor-recurrence-following-radiotherapy-56205https://curecurrent.com/trials/ipilimumab-with-nivolumab-for-molecular-selected-patients-with-castration-resistant-prostate-cancer-56206https://curecurrent.com/trials/cognitive-and-fusion-prostatic-biopsy-56207https://curecurrent.com/trials/interest-of-trimodality-pet-ct-choline-mri-before-radiotherapy-in-high-risk-prostate-cancer-56208https://curecurrent.com/trials/dynamic-68ga-psma-and-18f-fdg-pet-ct-analysis-prior-to-177lu-psma-56209https://curecurrent.com/trials/a-study-of-radiation-dosimetry-safety-and-tolerability-of-extended-lutetium-177lu-vipivotide-tetraxetan-treatment-in-che-56210https://curecurrent.com/trials/randomized-phase-ii-trial-of-targeted-radiation-with-no-castration-for-mcrpc-56211https://curecurrent.com/trials/a-study-to-learn-about-novel-hormonal-therapies-in-people-with-metastatic-castration-sensitive-prostate-cancer-mcspc-56212https://curecurrent.com/trials/community-based-health-coach-for-access-to-germline-genetic-testing-among-african-american-men-with-prostate-cancer-56213https://curecurrent.com/trials/s1216-phase-iii-adt-tak-700-vs-adt-bicalutamide-for-metastatic-prostate-cancer-56214https://curecurrent.com/trials/retrospective-prospective-analysis-of-surgical-outcomes-of-robotic-prostatectomy-at-the-james-56215https://curecurrent.com/trials/intrinsic-validity-of-molecular-marker-s-detection-on-tissular-tumoral-dna-to-predict-the-efficacy-of-177lutetium-psma-6-56216https://curecurrent.com/trials/trial-of-ultrahypofractionated-focal-salvage-radiotherapy-for-isolated-prostate-bed-recurrence-after-radical-prostatecto-56217https://curecurrent.com/trials/68ga-psma-0057-and-177lu-psma-0057-in-patients-with-psma-positive-metastatic-castration-resistant-prostate-cancer-56218https://curecurrent.com/trials/a-study-of-salvage-radiotherapy-with-or-without-enzalutamide-in-recurrent-prostate-cancer-following-surgery-56219https://curecurrent.com/trials/diet-physical-activity-and-related-candidate-biomarkers-in-relation-to-prostate-cancer-risk-biocappe-56220https://curecurrent.com/trials/dapagliflozin-combined-with-next-generation-hormonal-agent-nha-versus-single-nha-in-participants-with-metastatic-castrat-56221https://curecurrent.com/trials/limited-versus-extended-lymph-node-dissection-during-radical-prostatectomy-in-patients-with-localized-or-locally-advance-56222https://curecurrent.com/trials/study-to-assess-177lu-lu-psma-r2-aaa602-and-225ac-ac-psma-r2-aaa802-in-participants-with-psma-positive-hrlpc-56223https://curecurrent.com/trials/fostering-shared-decision-making-about-prostate-cancer-screening-among-clinicians-and-african-american-men-56224https://curecurrent.com/trials/comparison-of-the-integrated-posterior-anterior-lateral-approach-and-the-posterior-approach-in-robotic-radical-prostatec-56225https://curecurrent.com/trials/prospective-evaluation-of-imaging-response-biomarkers-during-177lu-lu-psma-in-metastatic-castration-resistant-prostate-c-56226https://curecurrent.com/trials/four-timepoint-multi-tracer-pet-imaging-to-characterize-metastatic-prostate-cancer-heterogeneity-56227https://curecurrent.com/trials/light-therapy-and-occupational-therapy-fatigue-management-based-intervention-for-patients-with-genitourinary-cancers-56228https://curecurrent.com/trials/acutens-for-pain-relief-during-trus-guided-prostate-biopsy-56229https://curecurrent.com/trials/quantification-with-lutetium-177-on-cadmium-zinc-telluride-camera-3d-56230https://curecurrent.com/trials/early-magnetic-resonance-imaging-response-of-the-dominant-intraprostatic-lesion-after-online-adaptive-stereotactic-body-56231https://curecurrent.com/trials/prostate-biopsy-transrectal-vs-transperineal-efficacy-and-complications-56232https://curecurrent.com/trials/cancer-dna-detection-in-blood-and-urine-56233https://curecurrent.com/trials/ablative-therapy-in-the-management-of-prostate-cancer-56234https://curecurrent.com/trials/castration-with-abiraterone-250-mg-without-lhrh-analogs-or-blockers-in-patients-with-prostate-cancer-requiring-hormonal-56235https://curecurrent.com/trials/detecting-metastases-by-pyl-pet-ct-in-subjects-starting-enzalutamide-for-untreated-castration-resistant-prostate-cancer-56236https://curecurrent.com/trials/a-study-to-assess-the-safety-pharmacokinetics-and-anti-tumor-activity-of-oral-hp518-in-mcrpc-patients-56237https://curecurrent.com/trials/study-to-evaluate-the-safety-and-tolerability-of-cc-94676-in-participants-with-metastatic-castration-resistant-prostate-56238https://curecurrent.com/trials/an-efficacy-and-safety-study-of-niraparib-in-men-with-metastatic-castration-resistant-prostate-cancer-and-dna-repair-ano-56239https://curecurrent.com/trials/symmcora-long-term-bidirectional-barbed-suture-for-anastomosis-in-patients-undergoing-robot-assisted-radical-prostatecto-56240https://curecurrent.com/trials/a-study-of-nivolumab-plus-ipilimumab-ipilimumab-alone-or-cabazitaxel-in-men-with-metastatic-castration-resistant-prostat-56241https://curecurrent.com/trials/vascular-optimized-radiotherapy-tuned-to-critical-structures-for-erectile-function-using-high-precision-x-ray-treatment-56242https://curecurrent.com/trials/evaluation-of-a-targeted-magnetic-resonance-imaging-contrast-agent-in-prostate-cancer-patients-56243https://curecurrent.com/trials/effects-of-epa-in-men-with-biochemical-recurrence-or-progression-of-prostate-cancer-56244https://curecurrent.com/trials/creation-of-an-image-database-for-the-development-of-a-computer-aided-diagnostic-cad-system-in-patients-with-prostate-ca-56245https://curecurrent.com/trials/radium-223-and-sabr-versus-sabr-for-oligometastatic-prostate-cancers-56246https://curecurrent.com/trials/assessment-of-prostate-mri-before-prostate-biopsies-56247https://curecurrent.com/trials/scipi-implementation-and-evaluation-a-multi-site-proof-of-concept-pilot-trial-56248https://curecurrent.com/trials/kzr-261-in-subjects-with-advanced-solid-malignancies-56249https://curecurrent.com/trials/study-of-tgf-receptor-inhibitor-galunisertib-ly2157299-and-enzalutamide-in-metastatic-castration-resistant-prostate-canc-56250https://curecurrent.com/trials/transperineal-mri-guided-prostate-biopsy-56251https://curecurrent.com/trials/a-study-of-androgen-annihilation-in-high-risk-biochemically-relapsed-prostate-cancer-56252https://curecurrent.com/trials/study-of-cabozantinib-in-combination-with-atezolizumab-versus-second-nht-in-subjects-with-mcrpc-56253https://curecurrent.com/trials/psma-pet-directed-radiation-therapy-for-high-risk-prostate-cancer-56254https://curecurrent.com/trials/personalized-optimization-of-systematic-prostate-biopsy-56255https://curecurrent.com/trials/extension-study-investigating-the-long-term-safety-of-degarelix-one-month-depots-in-patients-with-prostate-cancer-56256https://curecurrent.com/trials/reduction-of-gastrointestinal-toxicity-in-prostate-cancer-by-proton-spot-placement-56257https://curecurrent.com/trials/4-aminopyridine-treatment-for-nerve-injury-56258https://curecurrent.com/trials/focal-laser-ablation-of-low-to-intermediate-prostate-cancer-tumors-56259https://curecurrent.com/trials/prostate-cancer-prospective-cohort-56260https://curecurrent.com/trials/the-genpet-study-an-imaging-study-of-fch-pet-ct-in-men-with-prostate-cancer-and-a-dna-repair-gene-mutation-56261https://curecurrent.com/trials/precision-medicine-in-the-prostate-cancer-care-pathway-56262https://curecurrent.com/trials/role-of-race-in-nutritional-approach-in-men-on-adt-56263https://curecurrent.com/trials/a-registry-study-to-observe-clinical-outcomes-of-participants-with-high-risk-metastatic-hormone-na-ve-prostate-cancer-in-56264https://curecurrent.com/trials/intrepid-intermediate-risk-erection-preservation-trial-56265https://curecurrent.com/trials/darolutamide-adt-post-rp-w-o-eplnd-in-hrpc-briganti-2019-56266https://curecurrent.com/trials/dna-methylation-in-adenocarcinoma-of-the-prostate-analysis-of-validated-biomarkers-in-urine-56267https://curecurrent.com/trials/adjuvant-prostvac-v-f-in-subjects-at-high-risk-for-relapse-after-radical-prostatectomy-56268https://curecurrent.com/trials/medico-economic-comparison-of-robot-assisted-radical-prostatectomy-versus-radical-prostatectomy-via-laparotomy-56269https://curecurrent.com/trials/psma-pet-mri-unfavorable-risk-target-volume-pilot-study-56270https://curecurrent.com/trials/evaluation-of-response-to-abiraterone-prednisone-by-race-ethnicity-and-other-factors-in-metastatic-hormone-naive-prostat-56271https://curecurrent.com/trials/canada-wide-implementation-of-a-virtual-sexual-health-and-rehabilitation-eclinic-shareclinic-for-prostate-cancer-patient-56272https://curecurrent.com/trials/description-of-relugolix-use-in-patients-with-prostate-cancer-within-the-vha-56273https://curecurrent.com/trials/androgen-ablation-therapy-with-or-without-chemotherapy-in-treating-patients-with-metastatic-prostate-cancer-56274https://curecurrent.com/trials/mr-linac-guided-ultra-hypofractionated-rt-for-prostate-cancer-smart-p01-and-smart-p02-56275https://curecurrent.com/trials/rct-of-nlp-based-feedback-for-improving-sdm-in-men-with-localized-prostate-cancer-56276https://curecurrent.com/trials/an-expanded-access-protocol-for-apalutamide-treatment-of-participants-with-non-metastatic-castration-resistant-prostate-56277https://curecurrent.com/trials/ebrt-lu-psma-for-n1m0-prostate-cancer-56278https://curecurrent.com/trials/psma-pet-mri-ultrasound-multimodal-fusion-navigation-for-da-vinci-robot-assisted-radical-prostatectomy-a-randomized-cont-56279https://curecurrent.com/trials/radioligand-therapy-after-psma-pet-guided-external-beam-radiotherapy-for-treating-post-prostatectomy-patients-with-bioch-56280https://curecurrent.com/trials/electroacupuncture-in-the-treatment-of-patients-undergoing-transperineal-prostate-biopsy-under-local-anesthesia-56281https://curecurrent.com/trials/rectal-spacer-for-prostate-cancer-radiation-image-guidance-56282https://curecurrent.com/trials/a-study-to-learn-about-two-medicines-apalutamide-and-enzalutamide-in-people-with-metastatic-castration-sensitive-prostat-56283https://curecurrent.com/trials/evaluation-of-rapid-t2-weighted-and-dwi-mr-sequences-reconstructed-by-deep-learning-for-prostate-imaging-56284https://curecurrent.com/trials/robot-assisted-prostate-biopsy-with-a-novel-ultrasound-probe-56285https://curecurrent.com/trials/comparison-of-the-diagnosis-time-of-vet-and-scl-in-patients-with-intraoperative-coagulopathy-56286https://curecurrent.com/trials/convert-hb1-radical-prostatectomy-after-systemic-therapy-for-high-volume-metastatic-hormone-sensitive-prostate-cancer-56287https://curecurrent.com/trials/assessing-the-feasibility-of-web-based-insomnia-treatment-among-prostate-cancer-survivors-56288https://curecurrent.com/trials/remote-telemonitoring-of-patient-generated-physiologic-health-data-and-patient-reported-outcomes-56289https://curecurrent.com/trials/phase-ib-study-of-hs-20093-hrs-5041-in-patients-with-advanced-prostate-cancer-56290https://curecurrent.com/trials/virtual-biopsy-of-prostate-cancer-using-psma-pet-and-ai-56291https://curecurrent.com/trials/designing-visual-tools-to-enhance-cancer-surgeon-decision-making-56292https://curecurrent.com/trials/pembrolizumab-sd-101-in-hormone-na-ve-oligometastatic-prostate-cancer-with-rt-and-iadt-56293https://curecurrent.com/trials/study-of-robot-assisted-radical-prostatectomy-performed-on-outpatient-in-patients-with-localized-prostate-cancer-56294https://curecurrent.com/trials/intermittent-androgen-deprivation-therapy-for-stage-iv-castration-sensitive-prostate-cancer-56295https://curecurrent.com/trials/feasibility-of-prostatic-arterial-embolization-in-low-risk-patients-with-unilateral-prostate-cancer-under-active-surveil-56296https://curecurrent.com/trials/intracavernous-bone-marrow-stem-cell-injection-for-post-prostatectomy-erectile-dysfunction-56297https://curecurrent.com/trials/biobank-for-african-american-prostate-cancer-research-in-florida-56298https://curecurrent.com/trials/sequential-imaging-of-suspicion-of-prostate-cancer-reducing-overdiagnosis-and-unnecessary-biopsy-with-timely-diagnosis-o-56299https://curecurrent.com/trials/first-strike-second-strike-therapies-for-high-risk-metastatic-castration-sensitive-prostate-cancer-56300https://curecurrent.com/trials/darolutamide-in-addition-to-standard-androgen-deprivation-therapy-and-docetaxel-in-metastatic-hormone-sensitive-prostate-56301https://curecurrent.com/trials/drg-mutations-in-prostate-cancer-a-guiding-light-for-enhanced-screening-and-personalised-therapy-56302https://curecurrent.com/trials/comparison-of-peak-expiratory-flow-changes-after-robot-assisted-versus-open-radical-prostatectomy-56303https://curecurrent.com/trials/utility-of-adding-mr-fusion-to-standard-us-guided-prostate-biopsy-56304https://curecurrent.com/trials/ejaculatory-behavior-and-seminal-vesicle-size-during-radical-prostatectomy-56305https://curecurrent.com/trials/apa-enza-short-study-shorter-treatment-with-androgen-receptor-pathway-inhibitor-in-patients-with-low-volume-metastatic-c-56306https://curecurrent.com/trials/lu-psma-and-stereotactic-radiotherapy-versus-radiotherapy-alone-for-prostate-cancer-lust-56307https://curecurrent.com/trials/mri-guided-prostate-biopsy-56308https://curecurrent.com/trials/neoadjuvant-interstitial-brachytherapy-using-diffusing-alpha-emitters-radiation-therapy-in-men-with-prostate-cancer-56309https://curecurrent.com/trials/guidance-in-prostate-cancer-detection-with-18f-psma-1007-pet-mri-and-targeted-biopsies-56310https://curecurrent.com/trials/technology-enhanced-acceleration-of-germline-evaluation-for-therapy-target-study-56311https://curecurrent.com/trials/mri-for-assessing-prostate-cancer-response-56312https://curecurrent.com/trials/prostate-resection-after-microwave-ablation-prama-56313https://curecurrent.com/trials/effect-of-changes-in-endotracheal-tube-cuff-pressure-on-postoperative-pharyngolaryngeal-complications-in-robotic-surgery-56314https://curecurrent.com/trials/neoadjuvant-embolization-and-cytoreduction-in-prostate-cancer-56315https://curecurrent.com/trials/a-clinical-study-on-the-efficacy-and-safety-of-fasudil-hydrochloride-combined-with-immunotherapy-in-the-treatment-of-met-56316https://curecurrent.com/trials/aron-3-study-international-multicentric-retrospective-study-to-collect-global-experiences-in-the-treatment-of-patients-w-56317https://curecurrent.com/trials/medtronic-hugo-robotic-assisted-surgery-ras-system-in-urologic-surgery-expand-uro-56318https://curecurrent.com/trials/clinical-trial-of-tb511-in-advanced-solid-tumors-56319https://curecurrent.com/trials/circulating-tumor-cell-analysis-in-patients-with-localized-prostate-cancer-undergoing-prostatectomy-56320https://curecurrent.com/trials/mr-microstructural-imaging-for-prostate-cancer-diagnosis-56321https://curecurrent.com/trials/abiraterone-acetate-for-castrate-resistant-prostate-cancer-56322https://curecurrent.com/trials/enzalutamide-radiation-therapy-and-hormone-therapy-in-treating-patients-with-intermediate-or-high-risk-prostate-cancer-56323https://curecurrent.com/trials/electroacupuncture-for-improving-urinary-incontinence-after-radical-prostatectomy-56324https://curecurrent.com/trials/impact-of-a-physical-activity-intervention-with-motivational-support-from-peers-for-prostate-cancer-patients-56325https://curecurrent.com/trials/combination-study-of-antibiotics-with-enzalutamide-promize-56326https://curecurrent.com/trials/interstitial-assessment-of-architectural-heterogeneity-in-prostate-cancer-using-a-fine-needle-photoacoustic-probe-56327https://curecurrent.com/trials/evaluation-of-early-home-return-in-patients-with-enucleation-of-prostate-adenoma-56328https://curecurrent.com/trials/utility-of-biparametric-mri-magnetic-resonance-imaging-as-a-screening-tool-for-prostate-cancer-in-a-high-risk-cohort-56329https://curecurrent.com/trials/molecular-mechanisms-of-dutasteride-and-dietary-interventions-to-prevent-prostate-cancer-and-reduce-its-progression-56330https://curecurrent.com/trials/68ga-xacp3-pet-ct-in-prostate-cancer-56331https://curecurrent.com/trials/study-of-tvb-2640-in-men-with-metastatic-castration-resistant-prostate-cancer-56332https://curecurrent.com/trials/spinal-anesthesia-for-robotic-assisted-laparoscopic-prostatectomy-56333https://curecurrent.com/trials/immuno-molecular-approaches-for-non-invasive-diagnosis-of-prostate-cancer-56334https://curecurrent.com/trials/study-of-current-practice-which-compare-the-rate-of-prostate-cancer-by-using-2-kind-of-transrectal-biopsies-3-by-irm-ech-56335https://curecurrent.com/trials/effects-of-epa-on-prostate-cancer-cells-proliferation-and-quality-of-life-56336https://curecurrent.com/trials/application-of-quantum-detection-driven-artificial-intelligence-algorithms-for-single-molecule-cfdna-characterization-in-56337https://curecurrent.com/trials/test-semiquantitative-prostate-specific-antigen-psa-56338https://curecurrent.com/trials/a-prospective-evaluation-of-early-acupuncture-for-immediate-continence-enhancement-after-prostatectomy-56339https://curecurrent.com/trials/memantine-hydrochloride-in-prostate-cancer-patients-56340https://curecurrent.com/trials/evaluating-safety-and-efficacy-of-prostate-sparing-radical-cystectomy-56341https://curecurrent.com/trials/effect-of-ruxolitinib-on-tumor-infiltrating-myeloid-cells-56342https://curecurrent.com/trials/immune-biomarkers-in-prostate-cancer-patients-treated-with-brachytherapy-56343https://curecurrent.com/trials/clinical-study-of-fasudil-hydrochloride-and-pd1-inhibitor-combined-with-androgen-deprivation-in-neoadjuvant-therapy-of-p-56344https://curecurrent.com/trials/lifestyle-intervention-in-patients-with-metastatic-prostate-cancer-56345https://curecurrent.com/trials/prostate-cancer-burden-and-heterogeneity-evaluation-towards-liquid-biopsy-a-correlation-study-to-18fdcfpyl-pet-and-patie-56346https://curecurrent.com/trials/valid-biomarkers-in-blood-to-predict-the-response-to-therapy-in-prostate-cancer-patients-56347https://curecurrent.com/trials/homoharringtonine-plus-androgen-deprivation-therapy-in-the-neoadjuvant-treatment-of-prostate-cancer-a-single-arm-clinica-56348https://curecurrent.com/trials/prognostic-factors-in-prostate-cancer-for-patients-treated-by-watchful-waiting-56349https://curecurrent.com/trials/clinical-genetic-and-environmental-determinants-of-prostate-cancer-progression-56350https://curecurrent.com/trials/stereotactic-body-radiotherapy-vs-intensity-modulated-radiotherapy-in-prostate-cancer-56351https://curecurrent.com/trials/64cu-sar-bbn-for-identification-of-participants-with-recurrence-of-prostate-cancer-sabre-56352https://curecurrent.com/trials/a-study-to-learn-about-the-safety-of-talzenna-in-people-with-prostate-cancer-56353https://curecurrent.com/trials/pacritinib-for-biochemical-relapse-after-definitive-treatment-for-prostate-cancer-56354https://curecurrent.com/trials/folate-study-in-men-with-advanced-prostate-cancer-56355https://curecurrent.com/trials/pembrolizumab-with-combination-chemotherapy-in-treating-participants-with-locally-advanced-or-metastatic-small-cell-neur-56356https://curecurrent.com/trials/cabozantinib-and-abiraterone-with-checkpoint-inhibitor-immunotherapy-in-metastatic-hormone-sensitive-prostate-cancer-cab-56357https://curecurrent.com/trials/promote-identifying-predictive-markers-of-response-for-genitourinary-cancer-56358https://curecurrent.com/trials/decitabine-cedazuridine-and-enzalutamide-for-the-treatment-of-metastatic-castrate-resistant-prostate-cancer-56359https://curecurrent.com/trials/prime-boost-immunotherapeutic-trial-in-men-with-biochemical-recurrence-after-definitive-local-therapy-for-prostate-cance-56360https://curecurrent.com/trials/polygenic-risk-stratification-combined-with-mpmri-to-identify-clinically-relevant-prostate-cancer-56361https://curecurrent.com/trials/optimization-of-prostate-biopsy-micro-ultrasound-versus-mri-56362https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-localized-prostate-cancer-that-have-undergone-surgery-56363https://curecurrent.com/trials/understanding-of-genetics-by-men-at-risk-for-prostate-cancer-56364https://curecurrent.com/trials/testosterone-therapy-in-castration-resistant-prostate-cancer-56365https://curecurrent.com/trials/effect-of-text-message-reminders-on-m-isi-score-after-prostate-surgery-56366https://curecurrent.com/trials/high-dose-brachytherapy-boost-with-stereostatic-body-radiation-therapy-to-intermediate-or-higher-risk-prostate-cancer-56367https://curecurrent.com/trials/pilot-study-for-detection-of-psma-low-crpc-ne-tumors-with-fluciclovine-pet-ct-56368https://curecurrent.com/trials/prostate-tissue-biobank-56369https://curecurrent.com/trials/biomarker-monitoring-of-prostate-cancer-patients-with-rsi-mri-prosrsi-56370https://curecurrent.com/trials/psmatrack-tracking-changes-in-psma-pet-during-initial-therapy-for-metastatic-hormone-sensitive-prostate-cancer-56371https://curecurrent.com/trials/a-study-of-shorter-course-hormone-therapy-and-radiation-for-high-risk-prostate-cancer-56372https://curecurrent.com/trials/urolift-system-with-sabr-for-prostate-cancer-and-bph-56373https://curecurrent.com/trials/behavioral-exercise-training-for-men-undergoing-androgen-depr-therapy-for-prostate-ca-56374https://curecurrent.com/trials/the-effect-of-the-prostate-cancer-foundation-screening-guidelines-for-black-men-on-intention-to-screen-in-faith-based-co-56375https://curecurrent.com/trials/prostar-a-study-evaluating-cpi-1205-in-patients-with-metastatic-castration-resistant-prostate-cancer-56376https://curecurrent.com/trials/adaptive-radiation-therapy-for-men-with-intermediate-or-high-risk-prostate-cancer-56377https://curecurrent.com/trials/circulating-tumor-dna-in-high-risk-localized-prostate-cancer-56378https://curecurrent.com/trials/randomized-salvage-radiation-therapy-plus-enzalutamide-post-prostatectomy-56379https://curecurrent.com/trials/comparison-of-18f-rhpsma-7-3-pet-ct-with-and-without-furosemide-in-biochemical-recurrence-of-prostate-cancer-56380https://curecurrent.com/trials/spaceoar-system-rws-in-china-56381https://curecurrent.com/trials/whole-food-plant-based-diet-to-improve-outcomes-in-prostate-cancer-56382https://curecurrent.com/trials/an-asian-study-to-evaluate-efficacy-and-safety-of-oral-enzalutamide-in-progressive-metastatic-prostate-cancer-participan-56383https://curecurrent.com/trials/a-study-of-enzalutamide-plus-androgen-deprivation-therapy-adt-versus-placebo-plus-adt-in-patients-with-metastatic-hormon-56384https://curecurrent.com/trials/radiation-hypofractionation-via-extended-versus-accelerated-therapy-heat-for-prostate-cancer-56385https://curecurrent.com/trials/evaluation-of-the-change-in-psma-expression-in-prostate-cancer-in-response-to-hormonal-therapy-56386https://curecurrent.com/trials/randomized-phase-ii-study-of-adt-abiraterone-vs-adt-docetaxel-abiraterone-56387https://curecurrent.com/trials/psma-targeted-18f-dcfpyl-pet-mri-for-the-detection-of-prostate-cancer-56388https://curecurrent.com/trials/exercise-in-prostate-cancer-56389https://curecurrent.com/trials/study-of-diagnostic-performance-of-18f-ctt1057-in-bcr-56390https://curecurrent.com/trials/assessing-induction-of-double-strand-breaks-with-androgen-receptor-partial-agonist-in-patients-on-androgen-suppression-56391https://curecurrent.com/trials/observational-study-for-the-evaluation-of-long-term-safety-of-radium-223-used-for-the-treatment-of-metastatic-castration-56392https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-efficacy-of-acapatamab-in-subjects-with-mcrpc-56393https://curecurrent.com/trials/vitamin-b6-in-reducing-hot-flashes-in-participants-with-prostate-cancer-undergoing-antiandrogen-therapy-56394https://curecurrent.com/trials/a-study-of-focal-salvage-high-dose-rate-brachytherapy-for-prostate-gland-only-recurrence-56395https://curecurrent.com/trials/arctic-liquid-biomarkers-in-the-prospective-androgen-receptor-signaling-inhibitors-arsi-resistance-clinical-trials-56396https://curecurrent.com/trials/phase-ii-study-of-docetaxel-before-degarelix-in-patients-with-newly-diagnosed-metastatic-prostate-cancer-56397https://curecurrent.com/trials/i-131-1095-radioligand-plus-enzalutamide-vs-enzalutamide-for-mcrpc-that-progressed-during-abiraterone-arrow-56398https://curecurrent.com/trials/a-study-of-mgc018-in-combination-with-mgd019-in-participants-with-advanced-solid-tumors-56399https://curecurrent.com/trials/analyzing-the-composition-of-tears-and-blood-for-discovery-of-novel-signatures-of-aggressive-prostate-cancer-56400https://curecurrent.com/trials/a-study-of-cognitive-health-in-survivors-of-prostate-cancer-56401https://curecurrent.com/trials/prostate-sbrt-for-locally-recurrent-prostate-cancer-after-prior-radiotherapy-56402https://curecurrent.com/trials/68ga-psma-11-pet-imaging-for-diagnosing-prostate-cancer-a-head-to-head-comparison-with-mpmri-56403https://curecurrent.com/trials/fractionated-docetaxel-and-radium-223-in-metastatic-castration-resistant-prostate-cancer-56404https://curecurrent.com/trials/feasibility-of-timesaving-when-using-histolog-confocal-laser-endomicroscopy-for-margin-assessment-in-prostatectomy-speci-56405https://curecurrent.com/trials/study-of-diagnostic-performance-of-18f-ctt1057-for-psma-positive-tumors-detection-56406https://curecurrent.com/trials/side-effects-of-low-dose-rate-brachytherapy-and-ultra-hypofractionated-radiotherapy-in-low-to-intermediate-risk-prostate-56407https://curecurrent.com/trials/tb-psma-i-t-radionuclide-before-radical-prostatectomy-in-patients-with-locally-advanced-prostate-cancer-tbeforeprost-tri-56408https://curecurrent.com/trials/real-world-study-on-preoperative-application-of-rezvilutamide-56409https://curecurrent.com/trials/surveillance-or-focal-therapy-56410https://curecurrent.com/trials/177lu-p17-087-177lu-p17-088-in-patients-with-metastatic-castration-resistant-prostate-cancer-56411https://curecurrent.com/trials/impact-of-psa-based-screening-on-mortality-among-men-aged-75-79-target-trial-emulation-56412https://curecurrent.com/trials/decreasing-dosing-regimens-of-abiraterone-500-mg-in-men-with-prostate-cancer-to-find-lowest-recommended-dose-56413https://curecurrent.com/trials/fusion-or-cognitive-ultrasound-guided-biopsy-to-detect-prostate-cancer-56414https://curecurrent.com/trials/treatment-of-cancer-related-bone-pain-by-using-bone-targeted-radiation-based-therapy-sn-117m-dtpa-in-patients-with-prost-56415https://curecurrent.com/trials/randomized-phase-ii-trial-on-short-term-darolutamide-concomitant-to-radiation-therapy-for-patients-with-intermediate-unf-56416https://curecurrent.com/trials/prowess-prostate-cancer-wearables-exercise-and-structured-supports-a-pilot-supportive-care-intervention-56417https://curecurrent.com/trials/study-to-assess-the-feasibility-of-stopping-prostate-cancer-treatment-early-in-elderly-patients-56418https://curecurrent.com/trials/genetic-testing-for-men-with-metastatic-prostate-cancer-56419https://curecurrent.com/trials/abbreviated-biparametric-mri-rsi-t2wi-for-prostate-cancer-detection-correlation-with-histopathology-56420https://curecurrent.com/trials/phase-i-ii-study-of-immunotherapy-combination-bn-brachyury-vaccine-m7824-n-803-and-epacadostat-quest1-56421https://curecurrent.com/trials/testosterone-and-olaparib-in-treating-patients-with-castration-resistant-prostate-cancer-56422https://curecurrent.com/trials/race-impact-on-efficacy-of-niraparib-plus-abiraterone-acetate-and-prednisone-in-patients-with-homologous-repair-deficien-56423https://curecurrent.com/trials/a-randomised-controlled-platform-trial-testing-treatments-in-metastatic-hormone-sensitive-prostate-cancer-56424https://curecurrent.com/trials/randomized-prospective-multi-center-cohort-study-for-primary-diagnosis-of-clinically-significant-prostate-cancer-with-co-56425https://curecurrent.com/trials/the-impact-study-identification-of-men-with-a-genetic-predisposition-to-prostate-cancer-56426https://curecurrent.com/trials/the-barcode-1-pilot-study-56427https://curecurrent.com/trials/evaluating-tolerability-of-epuhrt-with-brachytherapy-boost-56428https://curecurrent.com/trials/analysing-outcomes-after-prostate-cancer-diagnosis-and-treatment-in-carriers-of-rare-germline-mutations-56429https://curecurrent.com/trials/68ga-nta-476-imaging-in-prostate-cancer-56430https://curecurrent.com/trials/a-dosimetry-study-of-lutetium-177lu-rhpsma-10-1-and-lutetium-177lu-vipivotide-tetraxetan-pluvicto-in-patients-with-non-c-56431https://curecurrent.com/trials/connect2care-prostate-cancer-education-and-screenings-for-african-american-men-56432https://curecurrent.com/trials/focal-salvage-hdr-brachytherapy-for-locally-recurrent-prostate-cancer-in-patients-treated-with-prior-radiotherapy-56433https://curecurrent.com/trials/pembrolizumab-with-androgen-deprivation-therapy-and-radiotherapy-for-the-treatment-of-patients-with-high-risk-localized-56434https://curecurrent.com/trials/positron-emission-radiomics-with-psma-radioligands-on-newly-diagnosed-prostate-cancer-patients-56435https://curecurrent.com/trials/18f-fluciclovine-pet-in-metastatic-castration-resistant-prostate-cancer-treated-with-life-prolonging-therapies-56436https://curecurrent.com/trials/prospective-clinical-safety-and-efficacy-study-of-lesion-targeted-mri-tulsa-for-localized-prostate-cancer-56437https://curecurrent.com/trials/68ga-p16-093-and-68ga-psma-11-pet-ct-imaging-in-the-same-group-of-primary-prostate-cancer-patients-56438https://curecurrent.com/trials/imaging-study-to-investigate-safety-and-diagnostic-performance-of-18f-rhpsma-7-3-pet-ligand-in-suspected-prostate-cancer-56439https://curecurrent.com/trials/intermittent-androgen-deprivation-therapy-in-the-era-of-ar-pathway-inhibitors-56440https://curecurrent.com/trials/vidutolimod-cmp-001-in-combination-with-nivolumab-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-56441https://curecurrent.com/trials/post-marketing-clinical-follow-up-of-the-bioprotect-balloon-implant-system-56442https://curecurrent.com/trials/a-study-to-assess-how-radium-223-distributes-in-the-body-of-patients-with-prostate-cancer-which-spread-to-the-bones-56443https://curecurrent.com/trials/odm-201-vs-androgen-deprivation-therapy-in-hormone-na-ve-prostate-cancer-56444https://curecurrent.com/trials/phase-iii-radium-223-mcrpc-peace-iii-56445https://curecurrent.com/trials/impact-of-apalutamide-in-metastatic-hormone-sensitive-prostate-cancer-patients-56446https://curecurrent.com/trials/sacituzumab-tirumotecan-in-combination-with-tagitanlimab-in-the-treatment-of-aggressive-variant-prostate-cancer-avpc-and-56447https://curecurrent.com/trials/circulating-and-intra-tumoral-chemokines-in-patients-with-prostate-cancer-56448https://curecurrent.com/trials/comparison-of-high-dose-rate-brachytherapy-and-stereotactic-ablative-radiotherapy-as-monotherapy-for-the-treatment-of-lo-56449https://curecurrent.com/trials/personalized-radiotherapy-for-biochemical-recurrence-of-prostate-cancer-after-prostatectomy-56450https://curecurrent.com/trials/prospective-evaluation-of-a-commercially-available-hydrogel-spacer-56451https://curecurrent.com/trials/retrospective-evaluation-of-commercial-spacers-in-prostate-cancer-patients-56452https://curecurrent.com/trials/clinical-trial-to-evaluate-the-tolerance-of-tqb3201-tablets-56453https://curecurrent.com/trials/study-on-triple-therapy-combined-with-hifu-for-high-tumor-burden-mhspc-56454https://curecurrent.com/trials/stereotactic-body-radiation-therapy-sbrt-for-prostate-cancer-56455https://curecurrent.com/trials/study-of-psma-pet-ct-imaging-to-help-select-men-with-low-risk-prostate-cancer-for-active-surveillance-56456https://curecurrent.com/trials/vudalimab-xmab20717-in-combination-with-standard-of-care-treatment-in-patients-with-metastatic-castration-sensitive-pros-56457https://curecurrent.com/trials/apalutamide-and-abiraterone-acetate-in-african-american-and-caucasian-men-with-metastatic-castrate-resistant-prostate-ca-56458https://curecurrent.com/trials/radioligand-for-local-radiorecurrent-prostate-cancer-56459https://curecurrent.com/trials/pelvic-nodes-ultra-hypo-vs-conventionally-fractionated-imrt-with-hdr-boost-in-prostate-cancer-56460https://curecurrent.com/trials/a-study-of-amg-757-in-participants-with-neuroendocrine-prostate-cancer-56461https://curecurrent.com/trials/standard-systemic-therapy-with-or-without-definitive-treatment-in-treating-participants-with-metastatic-prostate-cancer-56462https://curecurrent.com/trials/health-gatherings-for-your-health-after-cancer-56463https://curecurrent.com/trials/pylarify-pet-ct-or-pet-mri-in-men-with-favorable-intermediate-risk-fir-prostate-cancer-56464https://curecurrent.com/trials/a-study-on-the-safety-and-efficacy-of-lae001-in-the-treatment-of-metastatic-prostate-cancer-56465https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-rifampicin-on-the-pharmacokinetics-of-oral-hrs-5041-in-healthy-subjects-56466https://curecurrent.com/trials/ultra-hypofractionnated-radiotherapy-with-hdr-brachytherapy-boost-56467https://curecurrent.com/trials/prehabilitation-to-patients-with-prostate-cancer-56468https://curecurrent.com/trials/effects-of-triptorelin-pamoate-6-month-when-given-to-adult-chinese-participants-with-advanced-cancer-in-the-prostate-56469https://curecurrent.com/trials/an-observational-study-of-radial-access-embolization-procedures-using-hydropearl-microspheres-56470https://curecurrent.com/trials/a-trial-of-triamcinolone-with-a-gnrh-analog-for-castration-resistant-prostate-cancer-56471https://curecurrent.com/trials/prostate-screening-study-using-mri-in-brca-carriers-56472https://curecurrent.com/trials/evaluation-of-68ga-dota-ir-780-c-4-in-pet-imaging-studies-for-psma-positive-prostate-cancer-patients-56473https://curecurrent.com/trials/improving-sexual-quality-of-life-randomized-trial-of-two-vs-five-mri-guided-sabr-treatments-for-prostate-cancer-56474https://curecurrent.com/trials/personalized-vs-fixed-activity-177lu-psma-617-radiopharmaceutical-therapy-prodigy-2-56475https://curecurrent.com/trials/comparative-study-of-diagnostic-and-prognosis-biomarkers-of-prostate-cancer-in-liquid-biopsy-hope-56476https://curecurrent.com/trials/clinical-study-on-neoadjuvant-therapy-of-homoharringtonine-combined-with-androgen-deprivation-for-prostate-cancer-56477https://curecurrent.com/trials/dietary-fiber-during-radiotherapy-a-placebo-controlled-randomized-trial-56478https://curecurrent.com/trials/a-digitally-distributed-yoga-intervention-in-prostate-cancer-rehabilitation-protocol-for-a-randomized-controlled-trial-56479https://curecurrent.com/trials/study-of-dose-escalation-of-abiraterone-actetate-in-prostate-cancer-56480https://curecurrent.com/trials/evaluation-of-needs-of-patients-and-care-givers-during-and-after-radiotherapy-of-patients-with-prostate-cancer-56481https://curecurrent.com/trials/the-impact-of-video-education-on-pain-and-anxiety-in-patients-undergoing-transrectal-ultrasonography-guided-prostate-bio-56482https://curecurrent.com/trials/a-study-of-patients-receiving-high-dose-rate-brachytherapy-56483https://curecurrent.com/trials/trans-rectal-focal-microwave-ablation-of-the-index-tumor-in-patients-with-low-risk-prostate-cancer-56484https://curecurrent.com/trials/evaluating-the-effects-of-frozen-section-technology-on-oncological-and-functional-outcomes-at-radical-prostatectomy-56485https://curecurrent.com/trials/prostate-cancer-diagnosis-by-multiparametric-ultrasound-wholemount-56486https://curecurrent.com/trials/a-novel-insight-into-crpc-progression-and-immune-evidence-from-single-cell-spatial-transcriptome-multi-omics-56487https://curecurrent.com/trials/long-term-outcomes-of-prostate-cancer-screening-56488https://curecurrent.com/trials/stereotactic-body-radiation-therapy-with-boost-using-urethral-sparing-intensity-modulated-radiation-therapy-planning-in-56489https://curecurrent.com/trials/is-002-phase-2-prostate-cancer-study-56490https://curecurrent.com/trials/adaptive-radiotherapy-for-high-risk-prostate-cancer-using-multiparametric-mri-56491https://curecurrent.com/trials/post-radiation-prostate-cancer-local-recurrences-detection-with-histoscanning-and-mri-56492https://curecurrent.com/trials/a-study-for-the-treatment-of-metastatic-prostate-cancer-with-hrs-1167-tablets-combined-with-abiraterone-acetate-tablets-56493https://curecurrent.com/trials/stereotactic-focal-radiotherapy-as-an-alternative-treatment-to-active-surveillance-for-low-and-intermediate-risk-prostat-56494https://curecurrent.com/trials/inbody-band-3-fitness-tracker-to-improve-health-outcomes-and-quality-of-life-in-black-prostate-cancer-survivors-56495https://curecurrent.com/trials/implementation-of-precision-medicine-in-high-risk-prostate-cancer-56496https://curecurrent.com/trials/multimodal-approach-in-patients-with-mhspc-randomized-trial-of-apa-adt-vs-apa-adt-and-local-treatment-56497https://curecurrent.com/trials/long-acting-neuraxial-peri-prostatic-block-in-cancer-56498https://curecurrent.com/trials/effect-of-androgen-deprivation-therapy-on-cardiovascular-function-in-prostate-cancer-56499https://curecurrent.com/trials/a-clinical-trial-evaluating-the-safety-and-tolerability-biodistribution-and-radiation-dosimetry-and-pharmacokinetics-of-56500https://curecurrent.com/trials/64cu-sar-bbn-and-67cu-sar-bbn-for-identification-and-treatment-of-gastrin-releasing-peptide-receptor-grpr-expressing-met-56501https://curecurrent.com/trials/68ga-psma-pet-ct-for-ra223-assessment-56502https://curecurrent.com/trials/hypofractionated-proton-radiation-therapy-for-low-and-intermediate-risk-prostate-cancer-56503https://curecurrent.com/trials/a-study-investigating-dna-damage-response-agents-in-molecularly-altered-advanced-cancer-56504https://curecurrent.com/trials/determination-of-assay-cut-off-for-the-radtox-test-in-prostate-cancer-patients-to-predict-gi-radiation-toxicity-56505https://curecurrent.com/trials/cyberknife-ultra-hypofractionated-sbrt-for-localized-prostate-cancer-56506https://curecurrent.com/trials/re-treatment-225ac-j591-for-mcrpc-56507https://curecurrent.com/trials/metastatic-castrate-resistant-prostate-cancer-subjects-treated-with-provenge-one-infusion-of-sipuleucel-t-56508https://curecurrent.com/trials/a-phase-ii-study-to-evaluate-the-safety-efficacy-and-pharmacokinetics-of-yl201-in-patients-with-mcrpc-56509https://curecurrent.com/trials/efficacy-and-safety-of-radical-prostatectomy-rp-with-or-without-salvage-radiotherapy-versus-rp-with-extended-pelvic-lymp-56510https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-tolerability-and-preliminary-efficacy-of-225ac-ac-psma-xt-injection-in-patients-56511https://curecurrent.com/trials/ivonescimab-in-the-treatment-of-multiple-advanced-tumors-56512https://curecurrent.com/trials/a-study-of-225ac-fpi-2059-in-adult-participants-with-solid-tumours-56513https://curecurrent.com/trials/hypofractionation-proton-beam-therapy-with-concurrent-treatment-of-prostate-and-pelvic-nodes-for-prostate-cancer-56514https://curecurrent.com/trials/prostate-cancer-biomarker-enrichment-and-treatment-selection-56515https://curecurrent.com/trials/enhanced-recovery-after-surgery-eras-pathway-in-patients-undergoing-robot-assisted-laparoscopic-radical-prostatectomy-56516https://curecurrent.com/trials/the-value-of-dual-parametric-magnetic-resonance-combined-with-regional-saturation-biopsy-in-patients-with-suspected-pros-56517https://curecurrent.com/trials/darolutamide-consolidation-radiotherapy-in-advanced-prostate-cancer-detected-by-psma-56518https://curecurrent.com/trials/primary-prostatic-lymphoma-on-a-66-year-old-male-in-mexico-56519https://curecurrent.com/trials/identifying-fundamental-mechanisms-of-skeletal-muscle-ageing-in-older-men-undergoing-androgen-deprivation-therapy-a-feas-56520https://curecurrent.com/trials/mri-guided-brachytherapy-and-salvage-sbrt-program-56521https://curecurrent.com/trials/comprehensive-versus-primary-tumor-radiotherapy-in-oligometastatic-prostate-cancer-56522https://curecurrent.com/trials/prostate-cancer-treatment-optimization-via-analysis-of-circulating-tumour-dna-56523https://curecurrent.com/trials/mri-guided-ultrahypofractionated-sbrt-prostate-program-56524https://curecurrent.com/trials/prostate-cancer-detection-rate-of-targeted-biopsies-with-pcavision-56525https://curecurrent.com/trials/hrqol-in-prostate-cancer-patients-treated-with-radiotherapy-56526https://curecurrent.com/trials/exploring-the-potential-of-robotic-telesurgery-in-remote-settings-56527https://curecurrent.com/trials/circulating-tumour-cells-as-biomarkers-to-predict-prostate-cancer-metastasis-for-treatment-stratification-of-cancer-56528https://curecurrent.com/trials/pivotal-study-of-mri-guided-transurethral-ultrasound-ablation-in-patients-with-localized-prostate-cancer-56529https://curecurrent.com/trials/study-of-relugolix-in-men-with-metastatic-castration-sensitive-prostate-cancer-or-non-metastatic-or-metastatic-castratio-56530https://curecurrent.com/trials/a-comparison-of-tulsa-procedure-vs-radical-prostatectomy-in-participants-with-localized-prostate-cancer-56531https://curecurrent.com/trials/high-intensity-focused-ultrasound-combined-with-novel-hormone-therapy-in-advanced-prostate-cancer-56532https://curecurrent.com/trials/neoadjuvant-phase-2-study-comparing-the-effects-of-ar-inhibition-with-without-src-or-mek-inhibition-in-prostate-cancer-56533https://curecurrent.com/trials/comparison-of-intermittent-androgen-deprivation-therapy-with-or-without-irradiation-recovery-in-prostate-cancer-patients-56534https://curecurrent.com/trials/prostate-cancer-awareness-and-initiative-for-screening-in-the-european-union-56535https://curecurrent.com/trials/prospective-validation-of-psma-rads-56536https://curecurrent.com/trials/feasibility-trial-of-single-dose-radiotherapy-for-localized-low-and-intermediate-risk-prostate-cancer-56537https://curecurrent.com/trials/impact-of-augmented-reality-during-robot-assisted-radical-prostatectomy-56538https://curecurrent.com/trials/tumor-directed-radiation-therapy-for-patients-with-the-highest-risk-category-of-localized-prostate-cancer-56539https://curecurrent.com/trials/collection-of-blood-in-studying-metabolites-in-patients-with-prostate-cancer-56540https://curecurrent.com/trials/liquid-biopsy-under-psma-radioligand-therapy-56541https://curecurrent.com/trials/a-study-using-available-data-to-learn-to-what-extent-patients-with-prostate-cancer-who-received-second-generation-androg-56542https://curecurrent.com/trials/durvalumab-and-olaparib-for-the-treatment-of-prostate-cancer-in-men-predicted-to-have-a-high-neoantigen-load-56543https://curecurrent.com/trials/diagnostic-efficacy-and-safety-of-flotufolastat-f-18-injection-in-subjects-with-biochemical-recurrence-of-prostate-cance-56544https://curecurrent.com/trials/clinical-study-of-rezvilutamide-combined-with-docetaxel-chemotherapy-in-the-treatment-of-abiraterone-resistant-prostate-56545https://curecurrent.com/trials/non-fucosylated-anti-ctla-4-bms-986218-degarelix-acetate-vs-degarelix-acetate-alone-in-men-with-high-risk-localized-pros-56546https://curecurrent.com/trials/robotic-arm-assisted-68-ga-psma-pet-ct-guided-prostate-biopsy-versus-mr-directed-cognitive-fusion-trus-guided-prostate-b-56547https://curecurrent.com/trials/feasibility-and-impact-of-liquid-biopsy-genomic-profiling-on-treatment-patients-with-metastatic-prostate-cancer-in-spain-56548https://curecurrent.com/trials/weight-loss-interventions-to-reduce-cancer-progression-in-prostate-cancer-patients-under-active-surveillance-56549https://curecurrent.com/trials/study-of-qlh12016-in-combination-with-novel-hormonal-agent-in-subjects-with-advanced-prostate-cancer-56550https://curecurrent.com/trials/study-of-tyk-00540-combined-with-enzalutamide-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-56551https://curecurrent.com/trials/study-of-ty-302-capsules-combined-with-abiraterone-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrp-56552https://curecurrent.com/trials/research-on-psma-targeted-intraoperative-fluorescent-imaging-agents-56553https://curecurrent.com/trials/systemic-and-tumor-directed-therapy-for-oligometastatic-prostate-cancer-56554https://curecurrent.com/trials/impact-of-multimodal-telerehabilitation-in-rural-patients-with-metastatic-prostate-cancer-56555https://curecurrent.com/trials/trial-of-lava-1207-in-patients-with-therapy-refractory-metastatic-castration-resistant-prostate-cancer-mcrpc-resistant-p-56556https://curecurrent.com/trials/erectile-dysfunction-in-good-prognosis-prostate-cancer-comparison-between-brachytherapy-and-stereotactic-body-radiothera-56557https://curecurrent.com/trials/a-study-of-177lu-lu-psma-xt-injection-in-patients-with-metastatic-prostate-cancer-56558https://curecurrent.com/trials/prostate-cancer-study-of-patient-experiences-56559https://curecurrent.com/trials/a-phase-iii-of-cabazitaxel-and-pelvic-radiotherapy-in-localized-prostate-cancer-and-high-risk-features-of-relapse-56560https://curecurrent.com/trials/combined-apalutamide-radiotherapy-and-lhrh-agonist-in-prostate-cancer-patients-after-prostatectomy-56561https://curecurrent.com/trials/prospective-observational-study-of-stereotactic-body-radiation-therapy-with-androgen-deprivation-therapy-for-organ-confi-56562https://curecurrent.com/trials/phase-ib-trial-of-177lu-psma-i-t-therapy-in-combination-with-olaparib-and-pembrolizumab-in-patients-with-metastatic-cast-56563https://curecurrent.com/trials/safety-and-tolerability-of-nox66-in-combination-with-palliative-radiotherapy-in-patients-with-late-stage-prostate-cancer-56564https://curecurrent.com/trials/psma-pet-imaging-of-salivary-gland-tumours-and-other-rare-cancers-56565https://curecurrent.com/trials/a-study-of-rucaparib-versus-physician-s-choice-of-therapy-in-participants-with-metastatic-castration-resistant-prostate-56566https://curecurrent.com/trials/the-profile-study-germline-genetic-profiling-correlation-with-targeted-prostate-cancer-screening-and-treatment-56567https://curecurrent.com/trials/effects-of-triptorelin-when-given-every-6-months-under-the-skin-to-adult-males-with-cancer-in-the-prostate-56568https://curecurrent.com/trials/imperial-prostate-7-prostate-assessment-using-comparative-interventions-fast-mri-and-image-fusion-for-cancer-56569https://curecurrent.com/trials/prostate-cancer-care-disparity-analysis-project-progap-56570https://curecurrent.com/trials/phase-1-trial-of-sync-t-immunotherapy-for-advanced-metastatic-castration-resistant-prostate-cancer-56571https://curecurrent.com/trials/active-surveillance-in-prostate-cancer-imaging-to-detect-radiographic-progression-as-an-endpoint-aspire-56572https://curecurrent.com/trials/adenosine-receptor-antagonist-combination-therapy-for-metastatic-castrate-resistant-prostate-cancer-56573https://curecurrent.com/trials/micro-ultrasound-for-prostate-cancer-diagnosis-56574https://curecurrent.com/trials/early-detection-of-prostate-cancer-of-syrian-men-56575https://curecurrent.com/trials/68ga-psma-11-pet-ct-screening-prior-to-177lu-psma-617-therapy-for-patients-with-metastatic-castrate-resistant-prostate-c-56576https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-plus-docetaxel-versus-placebo-plus-docetaxel-in-chemotherapy-na-ve-metastatic-castration-56577https://curecurrent.com/trials/gallium-ga-68-dotatate-pet-ct-in-diagnosing-patients-with-metastatic-castration-resistant-prostate-cancer-56578https://curecurrent.com/trials/prostate-cancer-imaging-in-early-detection-imagined-trial-56579https://curecurrent.com/trials/effect-of-treatment-on-work-experience-in-patients-with-stage-i-iii-prostate-cancer-56580https://curecurrent.com/trials/pilot-study-androgen-deprivation-therapy-impact-on-psma-pet-sensitivity-in-prostatectomy-staging-56581https://curecurrent.com/trials/efficacy-and-tolerability-of-low-dose-enzalutamide-in-prostate-cancer-56582https://curecurrent.com/trials/using-multiparametric-mri-to-evaluate-intraprostatic-tumor-responses-and-androgen-resistance-patterns-in-newly-diagnosed-56583https://curecurrent.com/trials/standardized-resistance-training-program-and-assessment-system-for-prostate-cancer-patients-receiving-androgen-deprivati-56584https://curecurrent.com/trials/efficacy-of-18f-psma-1007-pet-ct-in-patients-with-biochemial-recurrent-prostate-cancer-56585https://curecurrent.com/trials/bi836845-plus-enzalutamide-in-castrate-resistant-prostate-cancer-crpc-56586https://curecurrent.com/trials/liswt-for-nerve-sparing-radical-prostatectomy-ed-56587https://curecurrent.com/trials/registry-to-evaluate-long-term-outcomes-in-patients-who-undergo-68-ga-psma-11-pet-ct-imaging-evaluations-56588https://curecurrent.com/trials/long-term-prospective-registry-in-prostate-cancer-patients-from-diverse-urology-practice-settings-following-prolaris-tes-56589https://curecurrent.com/trials/mri-based-active-selection-for-treatment-trial-56590https://curecurrent.com/trials/in-men-with-metastatic-prostate-cancer-what-is-the-safety-and-benefit-of-lutetium-177-psma-radionuclide-treatment-in-add-56591https://curecurrent.com/trials/lu-psma-for-oligometastatic-prostate-cancer-treated-with-stereotactic-ablative-radiotherapy-56592https://curecurrent.com/trials/evaluating-the-effectiveness-of-the-nurse-ned-clinic-56593https://curecurrent.com/trials/drug-use-investigation-of-xofigo-castration-resistant-prostate-cancer-with-bone-metastases-56594https://curecurrent.com/trials/study-of-rates-of-prostate-cancer-diagnosis-in-men-of-african-ancestry-using-mri-and-mri-guided-biopsy-56595https://curecurrent.com/trials/phase-i-ii-clinical-study-of-hrs-1738-for-the-diagnosis-of-prostate-cancer-patients-56596https://curecurrent.com/trials/research-on-the-application-of-68ga-psma-cyc-pet-imaging-in-the-diagnosis-staging-and-restaging-of-prostate-cancer-56597https://curecurrent.com/trials/the-effect-of-pulsed-electromagnetic-field-therapy-on-muscle-mass-and-muscle-strength-in-prostate-cancer-patients-treate-56598https://curecurrent.com/trials/prospective-comparative-study-evaluating-the-early-complications-of-robot-assisted-radical-prostatectomy-performed-as-an-56599https://curecurrent.com/trials/bruog-337-olaparib-prior-to-radical-prostatectomy-for-advanced-prostate-cancer-defects-in-dna-repair-genes-56600https://curecurrent.com/trials/the-radium-select-study-56601https://curecurrent.com/trials/irish-programme-for-stratified-prostate-cancer-therapy-56602https://curecurrent.com/trials/vitamin-d-supplementation-in-rna-seq-profiles-of-single-core-prostate-samples-among-veterans-56603https://curecurrent.com/trials/trimodality-approach-of-low-dose-ionizing-radiation-with-or-without-neoadjuvant-pembrolizumab-and-prostatectomy-for-men-56604https://curecurrent.com/trials/impact-of-new-hormonotherapy-drugs-in-prostatic-cancer-on-the-risk-of-cardiovascular-events-a-pharmacoepidemiology-study-56605https://curecurrent.com/trials/toward-a-comprehensive-supportive-care-intervention-for-older-men-with-metastatic-prostate-cancer-56606https://curecurrent.com/trials/extended-vs-no-pelvic-lymph-node-dissection-during-radical-prostatectomy-dissection-2-0-56607https://curecurrent.com/trials/comparative-study-of-mri-and-tu-in-identifying-clinically-significant-prostate-cancer-among-ethnic-groups-56608https://curecurrent.com/trials/get-fit-prostate-a-randomized-controlled-exercise-trial-56609https://curecurrent.com/trials/comparison-of-mri-artificial-intelligence-guided-ctb-versus-routine-ctb-in-prostate-cancer-diagnosis-56610https://curecurrent.com/trials/conventional-versus-hypofractionated-radiation-in-high-risk-prostate-patients-56611https://curecurrent.com/trials/ltfu-for-all-cell-and-gene-therapy-studies-56612https://curecurrent.com/trials/the-impact-of-metastatic-directed-radiotherapy-mdrt-on-oligoprogressive-castration-resistant-prostate-cancer-crpc-56613https://curecurrent.com/trials/deadt-living-well-with-prostate-cancer-56614https://curecurrent.com/trials/prostate-cancer-treatment-using-stereotactic-radiotherapy-for-oligometastases-ablation-in-hormone-sensitive-patients-56615https://curecurrent.com/trials/detection-of-clinically-significant-prostate-cancer-with-18f-dcfpyl-pet-mr-56616https://curecurrent.com/trials/evaluation-of-a-multimodal-strategy-for-early-diagnosis-of-men-at-high-genetic-risk-of-prostate-cancer-56617https://curecurrent.com/trials/single-fractions-sbrt-for-prostate-cancer-56618https://curecurrent.com/trials/vaccination-in-early-and-advanced-prostate-cancer-56619https://curecurrent.com/trials/outpatient-holmium-laser-enucleation-of-the-prostate-benefit-of-moses-tm-2-0-technology-56620https://curecurrent.com/trials/postop-hypofractionated-radiation-therapy-and-lhrh-in-patients-with-prostate-cancer-56621https://curecurrent.com/trials/a-study-of-shr3680-in-combination-with-shr3162-in-the-treatment-of-mcrpc-56622https://curecurrent.com/trials/evaluation-of-the-interest-of-hyaluronic-acid-in-the-preservation-of-sexual-function-during-prostate-curietherapies-56623https://curecurrent.com/trials/evaluation-of-the-18f-psma-positron-emission-tomography-pet-ct-in-patients-with-medullary-thyroid-cancer-56624https://curecurrent.com/trials/evaluation-of-the-efficacy-of-darolutamide-triplet-therapy-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-56625https://curecurrent.com/trials/reminder-app-to-optimize-bladder-filling-during-radiotherapy-for-prostate-cancer-56626https://curecurrent.com/trials/therapeutics-in-early-prostate-cancer-taps02-56627https://curecurrent.com/trials/survey-on-lifestyle-perceived-barriers-and-development-of-change-in-patients-with-prostate-cancer-56628https://curecurrent.com/trials/high-dose-rate-hdr-brachytherapy-salvage-after-prostatectomy-56629https://curecurrent.com/trials/combination-immunotherapy-in-biochemically-recurrent-prostate-cancer-56630https://curecurrent.com/trials/prostate-pathway-embedded-comparative-trial-56631https://curecurrent.com/trials/creative-arts-therapy-on-body-image-self-esteem-anxiety-and-depression-in-post-treatment-prostate-cancer-patients-56632https://curecurrent.com/trials/safety-and-efficacy-trial-of-a-targeted-psma-fluorescent-contrast-agent-dgpr1008-for-intraoperative-imaging-of-prostate-56633https://curecurrent.com/trials/study-of-zg006-in-participants-with-neuroendocrine-prostate-cancer-56634https://curecurrent.com/trials/a-study-of-amg-340-in-subjects-with-metastatic-castrate-resistant-prostate-carcinoma-56635https://curecurrent.com/trials/pre-approval-access-single-patient-request-for-niraparib-abiraterone-acetate-combination-nira-aa-combination-56636https://curecurrent.com/trials/evaluation-of-targeted-biopsy-plus-sextant-biopsy-in-diagnosis-of-prostate-cancer-56637https://curecurrent.com/trials/neoadjuvant-and-adjuvant-abiraterone-acetate-apalutamide-prostate-cancer-undergoing-prostatectomy-56638https://curecurrent.com/trials/inside-identification-of-genomic-screening-pathways-in-cancer-patients-with-dna-repair-alterations-56639https://curecurrent.com/trials/pre-approval-single-patient-expanded-access-for-talazoparib-pf-06944076-56640https://curecurrent.com/trials/a-study-of-18-f-psma-1007-in-patients-with-known-or-suspected-metastatic-prostate-cancer-56641https://curecurrent.com/trials/an-observational-cohort-study-to-describe-and-compare-the-use-of-darolutamide-enzalutamide-and-apalutamide-and-how-well-56642https://curecurrent.com/trials/a-study-of-nivolumab-or-placebo-in-combination-with-docetaxel-in-men-with-advanced-castration-resistant-prostate-cancer-56643https://curecurrent.com/trials/discovery-of-biomarkers-for-intrinsic-radiation-sensitivity-in-cancer-patients-56644https://curecurrent.com/trials/synthetic-metabolic-and-genetic-networks-for-medical-diagnosics-56645https://curecurrent.com/trials/advanced-radiotherapy-art-in-prostate-cancer-prost-art-56646https://curecurrent.com/trials/study-of-chitosan-for-pharmacologic-manipulation-of-age-levels-in-prostate-cancer-patients-56647https://curecurrent.com/trials/feasibility-of-hormones-and-radiation-for-intermediate-or-high-risk-prostate-cancer-56648https://curecurrent.com/trials/a-study-of-bms-986218-or-bms-986218-plus-nivolumab-in-combination-with-docetaxel-in-participants-with-metastatic-castrat-56649https://curecurrent.com/trials/geriatric-assessment-and-technology-evaluation-in-prostate-cancer-56650https://curecurrent.com/trials/24-gy-in-one-fraction-urethral-sparing-hdr-like-sbrt-for-prostate-cancer-56651https://curecurrent.com/trials/phase-i-study-of-hsk46575-in-patients-with-metastatic-castration-resistant-prostate-cancer-56652https://curecurrent.com/trials/ipatasertib-plus-abiraterone-plus-prednisone-prednisolone-relative-to-placebo-plus-abiraterone-plus-prednisone-prednisol-56653https://curecurrent.com/trials/platelet-rich-plasma-during-radical-prostatectomy-56654https://curecurrent.com/trials/triptorelin-and-radiation-therapy-in-treating-patients-who-have-undergone-surgery-for-intermediate-risk-stage-iii-or-sta-56655https://curecurrent.com/trials/evaluation-of-the-safety-of-the-treatment-of-benign-prostatic-hyperplasia-by-high-intensity-focused-ultrasound-56656https://curecurrent.com/trials/novel-therapy-target-in-metastatic-prostate-cancer-56657https://curecurrent.com/trials/effects-of-music-and-conversation-in-prostate-biopsy-56658https://curecurrent.com/trials/curative-image-guided-radiotherapy-for-prostate-cancer-56659https://curecurrent.com/trials/state-of-play-of-physiotherapy-in-the-postoperative-management-of-prostate-cancer-prospective-monocentric-national-surve-56660https://curecurrent.com/trials/a-study-to-learn-about-novel-hormonal-therapies-nhts-for-metastatic-castration-sensitive-prostate-cancer-mcspc-in-people-56661https://curecurrent.com/trials/99mtc-qulic-5-p1-spect-imaging-in-patients-with-prostate-cancer-56662https://curecurrent.com/trials/ultralow-dose-pet-imaging-for-psma-expression-56663https://curecurrent.com/trials/determining-the-effect-of-abiraterone-on-the-metabolism-of-oxycodone-in-men-with-prostate-cancer-the-enable-study-56664https://curecurrent.com/trials/proton-boost-in-prostate-cancer-56665https://curecurrent.com/trials/real-world-prostate-cancer-registry-56666https://curecurrent.com/trials/preop-laxatives-in-robotic-urologic-surgery-56667https://curecurrent.com/trials/an-observational-study-of-radiotherapy-after-injection-of-spaceoar-hydrogel-56668https://curecurrent.com/trials/combining-epi-7386-with-enzalutamide-and-androgen-deprivation-therapy-for-metastatic-hormone-sensitive-prostate-cancer-56669https://curecurrent.com/trials/radiotherapy-or-surgery-combined-with-intense-androgen-deprivation-therapy-for-mcrpc-56670https://curecurrent.com/trials/epidemiologic-and-genetic-study-on-familial-prostate-cancer-56671https://curecurrent.com/trials/comparing-pre-anesthesia-evaluation-via-telemedicine-versus-in-person-for-surgical-patients-at-moffitt-cancer-center-56672https://curecurrent.com/trials/gp-extended-action-triptorelin-56673https://curecurrent.com/trials/pet-mri-for-the-staging-of-newly-diagnosed-prostate-cancer-56674https://curecurrent.com/trials/prostate-cancer-comparative-outcomes-of-new-conceptual-paradigms-for-treatment-56675https://curecurrent.com/trials/the-study-will-evaluate-if-leuprolide-mesylate-is-safe-and-effective-in-the-treatment-of-subjects-with-advanced-prostate-56676https://curecurrent.com/trials/predicting-operational-difficulties-and-outcomes-of-rarp-based-on-preoperative-assessment-introducing-the-piodo-question-56677https://curecurrent.com/trials/a-phase-1-2-study-of-177lu-nym032-injection-in-mcrpc-56678https://curecurrent.com/trials/pharmacokinetics-biodistribution-radiation-dose-and-safety-study-of-68ga-nym032-in-patients-56679https://curecurrent.com/trials/adenosine-signaling-modulation-and-immune-checkpoint-inhibition-with-hormone-sensitive-oligometastatic-prostate-cancer-56680https://curecurrent.com/trials/prostate-cancer-plasma-integrative-multi-modal-evaluation-56681https://curecurrent.com/trials/11c-yjh08-pet-imaging-for-detection-of-glucocorticoid-receptor-expression-56682https://curecurrent.com/trials/artificial-intelligence-ai-assisted-risk-based-prostate-cancer-detection-56683https://curecurrent.com/trials/improved-robotic-assisted-radical-prostatectomy-for-locally-advanced-prostate-cancer-bladder-suspension-and-preliminary-56684https://curecurrent.com/trials/post-prostatectomy-linac-based-ultrahypofractionated-radiotherapy-for-patients-with-localized-prostate-cancer-56685https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-plus-olaparib-versus-abiraterone-acetate-or-enzalutamide-in-metastatic-castration-resista-56686https://curecurrent.com/trials/contrast-enhanced-transrectal-ultrasonography-trus-to-assess-prostatic-vascularity-after-radiotherapy-xrt-56687https://curecurrent.com/trials/adherence-dynamics-for-whole-food-interventions-in-african-american-men-56688https://curecurrent.com/trials/samarium-153-with-neoadjuvant-hormonal-and-radiation-therapy-for-locally-advanced-prostate-cancer-56689https://curecurrent.com/trials/18f-dcfpyl-pet-ct-impact-on-treatment-strategies-for-patients-with-prostate-cancer-56690https://curecurrent.com/trials/biological-markers-and-advanced-imaging-for-prostate-cancer-progression-in-active-surveillance-56691https://curecurrent.com/trials/tulip-retrain-study-56692https://curecurrent.com/trials/durvalumab-with-or-without-tremelimumab-in-metastatic-castration-resistant-prostate-cancer-56693https://curecurrent.com/trials/stereotactic-body-radiotherapy-sbrt-post-prostatectomy-56694https://curecurrent.com/trials/cabazitaxel-with-radiation-and-hormone-therapy-for-prostate-cancer-56695https://curecurrent.com/trials/treatment-of-patients-with-progressive-mcrpc-with-177lu-psma-617-56696https://curecurrent.com/trials/evaluation-and-management-for-prostate-oncology-wellness-and-risk-empower-56697https://curecurrent.com/trials/maximal-tumor-eradication-for-oligometastatic-prostate-cancer-56698https://curecurrent.com/trials/a-trial-of-ipatasertib-in-combination-with-atezolizumab-56699https://curecurrent.com/trials/implementation-of-a-multimodal-prehabilitation-program-in-robotic-oncological-surgery-56700https://curecurrent.com/trials/value-of-ultra-fast-prostate-mri-in-prostate-cancer-56701https://curecurrent.com/trials/safety-and-early-efficacy-of-radical-prostatectomy-for-newly-diagnosed-very-high-risk-locally-advanced-and-oligometastat-56702https://curecurrent.com/trials/resistance-training-creatine-for-metastatic-prostate-cancer-patients-56703https://curecurrent.com/trials/177lu-psma-617-therapy-and-olaparib-in-patients-with-metastatic-castration-resistant-prostate-cancer-56704https://curecurrent.com/trials/salvage-lymph-node-dissection-in-prostate-cancer-patients-with-recurrence-after-radical-prostatectomy-56705https://curecurrent.com/trials/radiotherapy-combined-with-fluzopanib-and-abiraterone-acetate-tablets-ii-treatment-for-mcrpc-56706https://curecurrent.com/trials/177lu-psma-r2-in-patients-with-psma-positive-progressive-metastatic-castration-resistant-prostate-cancer-56707https://curecurrent.com/trials/arrx-in-combination-with-enzalutamide-in-metastatic-castration-resistant-prostate-cancer-56708https://curecurrent.com/trials/phase-1-2-clinical-study-of-lutetium-lu-177-jh020002-injection-in-patients-with-advanced-prostate-cancer-56709https://curecurrent.com/trials/spot-scanning-based-hypofractionated-proton-therapy-for-low-and-intermediate-risk-prostate-cancer-56710https://curecurrent.com/trials/exosomedx-in-mri-negative-men-with-high-psa-56711https://curecurrent.com/trials/enzalutamide-plus-talazoparib-for-the-treatment-of-hormone-sensitive-prostate-cancer-zz-first-56712https://curecurrent.com/trials/enzalutamide-versus-standard-androgen-deprivation-therapy-for-the-treatment-hormone-sensitive-prostate-cancer-56713https://curecurrent.com/trials/68ga-ga-psma-11-pet-ct-in-the-assessment-of-high-risk-and-recurrent-prostate-cancer-56714https://curecurrent.com/trials/recommended-dose-estimation-of-bp-c2-56715https://curecurrent.com/trials/prostate-radiation-therapy-or-short-term-androgen-deprivation-therapy-and-pelvic-lymph-node-radiation-therapy-with-or-wi-56716https://curecurrent.com/trials/study-of-srf617-with-ab928-etrumadenant-and-ab122-zimberelimab-in-patients-with-metastatic-castration-resistant-prostate-56717https://curecurrent.com/trials/multicenter-assessment-of-clinical-utility-pet-mr-with-the-use-of-the-radiotracer-68ga-psma-11-in-therapy-planning-perso-56718https://curecurrent.com/trials/immunotherapy-in-patients-with-metastatic-cancers-and-cdk12-mutations-56719https://curecurrent.com/trials/microwave-needle-thermoablation-for-treatment-of-localized-prostate-cancer-56720https://curecurrent.com/trials/real-life-evaluation-of-the-effect-of-adt-in-prostate-cancer-patients-in-asia-readt-asia-study-56721https://curecurrent.com/trials/patient-and-physician-benefit-risk-preferences-for-treatment-of-mpc-in-hong-kong-a-discrete-choice-experiment-56722https://curecurrent.com/trials/hong-kong-prostate-cancer-study-group-database-56723https://curecurrent.com/trials/a-multi-centre-trial-on-targeted-microwave-ablation-tma-for-localized-prostate-cancer-56724https://curecurrent.com/trials/to-evaluate-an-mri-based-optimized-prostate-cancer-diagnostic-pathway-powered-by-artificial-intelligence-56725https://curecurrent.com/trials/extended-systematic-versus-mri-assisted-prostate-transperineal-biopsy-56726https://curecurrent.com/trials/experiment-to-assess-preferences-for-novel-hormonal-therapy-and-androgen-deprivation-therapy-in-prostate-cancer-patients-56727https://curecurrent.com/trials/to-identify-potential-new-urine-markers-for-the-screening-of-prostate-cancer-56728https://curecurrent.com/trials/arfi-imaging-for-targeted-prostate-biopsy-56729https://curecurrent.com/trials/the-investigation-of-new-biological-markers-for-prostate-cancer-diagnosis-and-management-in-chinese-population-56730https://curecurrent.com/trials/alisertib-abiraterone-acetate-and-prednisone-in-treating-patients-with-hormone-resistant-prostate-cancer-56731https://curecurrent.com/trials/a-study-of-copanlisib-combined-with-rucaparib-in-patients-with-metastatic-castration-resistant-prostate-cancer-56732https://curecurrent.com/trials/digoxin-for-recurrent-prostate-cancer-56733https://curecurrent.com/trials/ultrasound-based-imaging-using-the-aixplorer-system-in-diagnosing-prostate-cancer-in-patients-undergoing-biopsy-56734https://curecurrent.com/trials/robotic-seed-implantation-for-prostate-cancer-brachytherapy-56735https://curecurrent.com/trials/impact-of-peri-operative-testosterone-levels-on-oncological-and-functional-outcomes-in-radical-prostatectomy-56736https://curecurrent.com/trials/virtual-reality-education-module-in-reducing-anxiety-and-increasing-knowledge-in-patients-with-prostate-cancer-undergoin-56737https://curecurrent.com/trials/copper-cu-64-tp3805-pet-in-detecting-cancer-in-patients-with-prostate-cancer-undergoing-surgery-56738https://curecurrent.com/trials/enzalutamide-and-metformin-hydrochloride-in-treating-patients-with-hormone-resistant-prostate-cancer-56739https://curecurrent.com/trials/continued-access-of-focal-mr-guided-focused-ultrasound-for-localized-intermediate-risk-prostate-lesions-56740https://curecurrent.com/trials/radium-223-and-radiotherapy-in-hormone-na-ve-men-with-oligometastatic-prostate-cancer-to-bone-56741https://curecurrent.com/trials/hypofractionation-for-prostate-cancer-in-africa-a-feasibility-study-56742https://curecurrent.com/trials/detection-of-high-grade-prostate-cancer-with-subharmonic-ultrasound-imaging-a-pilot-study-56743https://curecurrent.com/trials/pasireotide-som230-with-or-without-everolimus-in-treating-patients-with-hormone-resistant-chemotherapy-naive-prostate-ca-56744https://curecurrent.com/trials/focal-salvage-brachytherapy-study-focasabra-56745https://curecurrent.com/trials/ionm-during-radical-prostatectomy-56746https://curecurrent.com/trials/phase-ib-trial-of-radium-223-and-niraparib-in-patients-with-castrate-resistant-prostate-cancer-nirarad-56747https://curecurrent.com/trials/stereotactic-body-radiation-therapy-with-regn2810-and-or-ipilimumab-before-surgery-in-treating-participants-with-progres-56748https://curecurrent.com/trials/nivolumab-and-bms-986253-for-hormone-sensitive-prostate-cancer-magic-8-56749https://curecurrent.com/trials/genetic-evaluation-of-men-gem-56750https://curecurrent.com/trials/electronic-patient-reported-outcomes-in-measuring-health-related-quality-of-life-in-patients-with-stage-i-iv-prostate-ca-56751https://curecurrent.com/trials/the-barcode-1-study-full-study-the-use-of-genetic-profiling-to-guide-prostate-cancer-targeted-screening-56752https://curecurrent.com/trials/associations-between-chemotherapy-induced-nausea-in-patients-with-genitourinary-sarcoma-or-melanoma-cancers-and-changes-56753https://curecurrent.com/trials/efficacy-safety-and-pharmacokinetics-of-fp-014-22-5-mg-in-patients-with-advanced-prostate-cancer-56754https://curecurrent.com/trials/efficacy-safety-and-pharmacokinetics-of-fp-014-11-25-mg-in-patients-with-advanced-prostate-cancer-56755https://curecurrent.com/trials/exploring-the-correlation-between-mri-image-characteristics-and-diagnosis-pathology-and-prognosis-in-patients-with-prost-56756https://curecurrent.com/trials/regn2810-followed-by-chemoimmunotherapy-for-newly-metastatic-hormone-sensitive-prostate-cancer-56757https://curecurrent.com/trials/safe-nerve-sparing-guided-by-micro-ultrasound-mus-56758https://curecurrent.com/trials/immune-response-evaluation-in-oligorecurrent-and-oligoprogressive-prostate-cancer-patients-treated-with-sbrt-56759https://curecurrent.com/trials/copper-cu-64-tp3805-pet-in-detecting-prostate-cancer-in-patients-with-persistently-elevated-psa-56760https://curecurrent.com/trials/hyperpolarized-carbon-c-13-pyruvate-magnetic-resonance-spectroscopic-imaging-in-predicting-treatment-response-in-patient-56761https://curecurrent.com/trials/european-multicenter-validation-of-pcavision-a-head-to-head-diagnostic-accuracy-study-comparing-multiparametric-transrec-56762https://curecurrent.com/trials/study-of-xnw5004-tablet-in-combination-with-enzalutamide-in-subjects-with-metastatic-castration-resistant-prostate-cance-56763https://curecurrent.com/trials/novel-robotic-prostatectomy-technique-for-early-urinary-continence-56764https://curecurrent.com/trials/nerve-grafting-technique-to-restore-erectile-function-post-radical-prostatectomy-56765https://curecurrent.com/trials/goserelin-10-8mg-injection-in-treatment-of-advanced-prostate-cancer-56766https://curecurrent.com/trials/evaluation-of-the-prostia-test-in-patients-undergoing-prostate-biopsy-56767https://curecurrent.com/trials/evaluating-the-clinical-accuracy-of-gallium-68-psma-pet-ct-imaging-in-patients-with-biochemical-recurrence-of-prostate-c-56768https://curecurrent.com/trials/a-randomized-trial-of-early-detection-of-clinically-significant-prostate-cancer-proscreen-56769https://curecurrent.com/trials/oligos-impact-of-treatment-on-primary-tumour-in-patients-with-newly-diagnosed-oligometastatic-neoplasia-of-the-prostate-56770https://curecurrent.com/trials/effectiveness-safety-and-economic-evaluation-of-goserelin-microspheres-for-injection-and-goserelin-sustained-release-imp-56771https://curecurrent.com/trials/prospective-evaluation-of-cornerstone-robotics-sentire-surgical-system-in-major-gastrointestinal-and-urologic-surgery-56772https://curecurrent.com/trials/randomized-trial-of-hifu-vs-cryo-for-prostate-cancer-56773https://curecurrent.com/trials/preclude-infection-events-with-no-prophylaxis-transperineal-biopsy-56774https://curecurrent.com/trials/study-of-abiraterone-acetate-without-exogenous-glucocorticoids-in-men-with-castration-resistant-prostate-cancer-56775https://curecurrent.com/trials/docetaxel-versus-cabazitaxel-post-abiraterone-or-enzalutamide-56776https://curecurrent.com/trials/18f-psma-pet-mri-for-the-diagnosis-of-clinically-significant-prostate-cancer-56777https://curecurrent.com/trials/weight-management-aimed-to-reduce-risk-and-improve-outcomes-from-radical-prostatectomy-56778https://curecurrent.com/trials/phase-iii-clinical-trial-to-evaluate-inr101-injection-for-pet-ct-imaging-in-patients-with-prostate-cancer-56779https://curecurrent.com/trials/a-study-of-degarelix-in-taiwanese-patients-with-prostate-cancer-56780https://curecurrent.com/trials/ebastine-in-combination-with-docetaxel-as-a-treatment-for-castration-resistant-metastatic-prostate-cancer-56781https://curecurrent.com/trials/hydroxychloroquine-to-increase-tumor-suppressor-par-4-levels-in-oligometastatic-prostate-cancer-56782https://curecurrent.com/trials/systemic-light-exposure-in-preventing-frailty-in-older-patients-with-prostate-cancer-on-hormonal-therapy-56783https://curecurrent.com/trials/intratumoral-heterogeneity-on-18f-psma-and-18f-fdg-pet-ct-in-predicting-invasion-and-prognosis-of-prostate-cancer-56784https://curecurrent.com/trials/active-surveillance-exercise-clinical-trial-56785https://curecurrent.com/trials/a-multicenter-open-label-prospective-phase-iii-clinical-trial-to-evaluate-inr101-injection-for-pet-ct-imaging-in-partici-56786https://curecurrent.com/trials/3-tesla-mri-in-finding-tumors-in-patients-with-known-or-suspected-prostate-cancer-56787https://curecurrent.com/trials/evaluating-an-alternative-clinical-genetics-cancer-care-deliver-model-56788https://curecurrent.com/trials/probio-a-biomarker-driven-study-in-patients-with-metastatic-prostate-cancer-56789https://curecurrent.com/trials/evaluation-of-prostate-cancer-margins-56790https://curecurrent.com/trials/plx2853-in-combination-with-abiraterone-acetate-and-prednisone-and-in-combination-with-olaparib-in-subjects-with-metasta-56791https://curecurrent.com/trials/the-prognostic-value-of-pet-ct-for-tumor-progression-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-56792https://curecurrent.com/trials/evaluation-of-transrectal-perilesional-biopsy-in-diagnosis-of-prostate-cancer-56793https://curecurrent.com/trials/focal-laser-ablation-in-prostate-cancer-56794https://curecurrent.com/trials/a-study-to-assess-the-benefit-of-treatment-beyond-progression-with-enzalutamide-in-men-who-are-starting-treatment-with-d-56795https://curecurrent.com/trials/cabazitaxel-in-combination-with-177lu-psma-617-in-metastatic-castration-resistant-prostate-cancer-56796https://curecurrent.com/trials/psma-and-c-11-choline-pet-in-patients-with-biochemical-recurrence-of-prostate-cancer-56797https://curecurrent.com/trials/pet-ct-imaging-study-with-simultaneous-dual-nuclide-imaging-technique-56798https://curecurrent.com/trials/prehabilitation-in-prostate-cancer-patients-teleprehabtrial-56799https://curecurrent.com/trials/androgen-deprivation-therapy-for-oligo-recurrent-prostate-cancer-in-addition-to-radiotherapy-56800https://curecurrent.com/trials/analysis-of-immediate-urinary-continence-predictors-after-rs-rarp-56801https://curecurrent.com/trials/soy-bread-diet-in-improving-immune-function-in-participants-with-prostate-cancer-56802https://curecurrent.com/trials/the-application-of-somatosensory-interactive-pelvic-floor-muscle-training-for-stress-urinary-incontinence-in-men-underwe-56803https://curecurrent.com/trials/focal-prostate-ablation-versus-radical-prostatectomy-56804https://curecurrent.com/trials/accurate-prostate-cancer-following-using-low-field-mri-low-prism-56805https://curecurrent.com/trials/otago-exercises-on-the-risk-of-falling-in-prostatic-cancer-patients-receiving-androgen-deprivation-therapy-56806https://curecurrent.com/trials/es-hifu-prospective-data-collection-of-patients-treated-with-partial-gland-hifu-ablation-for-prostate-cancer-56807https://curecurrent.com/trials/autologous-t-cells-lentivirally-transduced-to-express-l1cam-specific-chimeric-antigen-receptors-in-treating-patients-wit-56808https://curecurrent.com/trials/the-role-of-wb-mri-in-the-evaluation-of-prostate-cancer-patients-treated-with-lutetium-prostate-specific-membrane-antige-56809https://curecurrent.com/trials/clinical-evaluation-of-177lu-dansyi-psma-lnc1011-in-patients-with-metastatic-castration-resistant-prostate-cancer-56810https://curecurrent.com/trials/trial-of-arv-110-in-patients-with-metastatic-castration-resistant-prostate-cancer-56811https://curecurrent.com/trials/the-added-value-of-psma-pet-in-detecting-clinically-significant-prostate-cancer-lesions-in-patients-undergoing-mri-targe-56812https://curecurrent.com/trials/observational-study-on-extreme-hypofractionation-for-localized-prostate-cancer-56813https://curecurrent.com/trials/prostate-specific-antigen-levels-of-individuals-living-in-rural-areas-56814https://curecurrent.com/trials/testing-the-effects-of-oxybutynin-for-the-treatment-of-hot-flashes-in-men-receiving-hormone-therapy-for-prostate-cancer-56815https://curecurrent.com/trials/the-diagnostic-application-of-psmapet-mr-in-patients-undergoing-secondary-prostate-puncture-56816https://curecurrent.com/trials/a-phase-1-2-study-of-personalized-psma-radiopharmaceutical-therapy-56817https://curecurrent.com/trials/study-evaluating-the-addition-of-pembrolizumab-to-radium-223-in-mcrpc-56818https://curecurrent.com/trials/needle-localization-during-prostate-brachytherapy-using-power-doppler-ultrasound-56819https://curecurrent.com/trials/prophylactic-prostatectomy-for-prostate-cancer-pppc-56820https://curecurrent.com/trials/genomics-and-efficacy-of-post-prostatectomy-salvage-radiotherapy-with-extreme-hypofractionation-56821https://curecurrent.com/trials/can-needle-size-improve-cancer-detection-rate-of-transperineal-mri-target-prostate-biopsy-without-affecting-side-effects-56822https://curecurrent.com/trials/a-study-of-grape-seed-extract-in-asymptomatic-non-metastatic-prostate-cancer-patients-with-rising-psa-56823https://curecurrent.com/trials/a-study-to-investigate-efficacy-and-safety-of-different-dose-regimen-of-oral-cabazitaxel-tablet-in-adult-participants-wi-56824https://curecurrent.com/trials/comparative-health-research-outcomes-of-novel-surgery-in-prostate-cancer-56825https://curecurrent.com/trials/cytoreductive-prostatectomy-versus-cytoreductive-prostate-irradiation-as-a-local-treatment-option-for-metastatic-prostat-56826https://curecurrent.com/trials/osteosclerotic-changes-on-ct-predict-survival-in-prostate-cancer-56827https://curecurrent.com/trials/a-single-center-prospective-interventional-study-on-fpg500-in-non-metastatic-prostate-cancer-patients-56828https://curecurrent.com/trials/impact-of-hormonal-therapy-on-prostate-cancer-recurrence-after-radical-prostatectomy-56829https://curecurrent.com/trials/comparing-salvage-radiotherapy-and-individualized-psma-pet-ct-targeted-treatment-in-with-relapsing-prostate-cancer-56830https://curecurrent.com/trials/pro-merit-prostate-cancer-messenger-rna-immunotherapy-56831https://curecurrent.com/trials/study-of-the-safety-tolerability-and-efficacy-of-kpt-8602-in-participants-with-relapsed-refractory-cancer-indications-56832https://curecurrent.com/trials/evaluation-of-psma-based-pet-as-an-imaging-biomarker-in-prostate-cancer-56833https://curecurrent.com/trials/abemaciclib-in-combination-with-androgen-deprivation-therapy-for-locally-advanced-prostate-cancer-56834https://curecurrent.com/trials/phase-1-study-to-evaluate-pk-safety-and-tolerability-of-hrs-5041-in-healthy-caucasian-male-participants-56835https://curecurrent.com/trials/telephone-paramedical-support-prior-to-the-radiotherapy-simulation-scanner-for-patients-with-prostate-cancer-56836https://curecurrent.com/trials/an-investigational-scan-7-tesla-mri-in-diagnosing-cognitive-impairment-in-patients-with-non-metastatic-prostate-cancer-56837https://curecurrent.com/trials/imaging-guided-surgery-to-improve-the-detection-of-lymph-node-metastases-in-prostate-cancer-patients-56838https://curecurrent.com/trials/a-study-of-tas0612-in-participants-with-advanced-or-metastatic-solid-tumor-cancer-56839https://curecurrent.com/trials/psma-pet-guided-radiotherapy-56840https://curecurrent.com/trials/penile-rehabilitation-after-nerve-sparing-robot-assisted-radical-prostatectomy-for-prostate-cancer-2-0-pehab-ii-56841https://curecurrent.com/trials/focal-hdr-brachytherapy-boost-to-stereotactic-radiotherapy-56842https://curecurrent.com/trials/characterization-of-microbiological-and-genetic-features-in-prostate-cancer-and-their-association-with-disease-stage-56843https://curecurrent.com/trials/stereotactic-re-irradiation-of-local-recurrences-of-prostate-cancer-after-radiotherapy-56844https://curecurrent.com/trials/psma-pet-ct-guided-intensification-of-therapy-in-patients-at-risk-of-advanced-prostate-cancer-56845https://curecurrent.com/trials/18f-florastamin-pet-ct-imaging-examination-in-patients-with-suspected-recurrent-or-metastatic-prostate-cancer-56846https://curecurrent.com/trials/new-treatment-modalities-for-localized-prostate-cancer-56847https://curecurrent.com/trials/psa-biochemical-response-as-prognostic-factor-in-metastatic-castration-sensitive-prostate-cancer-56848https://curecurrent.com/trials/a-trial-evaluating-the-efficacy-and-safety-of-hc-1119-soft-capsules-in-patients-with-metastatic-castration-resistant-pro-56849https://curecurrent.com/trials/real-life-experience-in-brazil-in-patients-with-castration-resistant-prostate-cancer-treated-with-olaparib-abiraterone-56850https://curecurrent.com/trials/evaluate-the-clinical-usefulness-of-f-18-florastamin-pet-ct-imaging-diagnosis-compared-to-mri-diagnosis-56851https://curecurrent.com/trials/european-registry-of-next-generation-imaging-in-advanced-prostate-cancer-56852https://curecurrent.com/trials/in-vivo-dosimetry-for-brachytherapy-study-56853https://curecurrent.com/trials/elimination-of-prostate-cancer-treatment-side-effects-using-a-nutraceutical-56854https://curecurrent.com/trials/single-port-versus-multi-port-robotic-radical-prostatectomy-56855https://curecurrent.com/trials/phase-1-clinical-study-of-gt-220f-in-subjects-with-metastatic-castration-resistant-prostate-cancer-mcrpc-56856https://curecurrent.com/trials/study-of-prostate-perfusion-before-embolization-in-patients-with-symptomatic-prostate-adenoma-56857https://curecurrent.com/trials/68ga-ga-p17-079-in-the-diagnosis-and-treatment-of-metastatic-prostate-cancer-56858https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-pk-evaluation-of-bz371a-topically-administered-56859https://curecurrent.com/trials/effectiveness-of-cryotherapy-study-for-prostate-cancer-56860https://curecurrent.com/trials/clinical-study-of-geranium-wilfordii-combined-with-androgen-deprivation-in-neoadjuvant-therapy-of-prostate-cancer-56861https://curecurrent.com/trials/a-prospective-bicentric-evaluation-of-fluciclovine-pet-imaging-in-patients-with-prior-negative-or-inconclusive-psma-liga-56862https://curecurrent.com/trials/epidiolex-cbd-in-patients-with-biochemically-recurrent-prostate-cancer-56863https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-preliminary-anti-tumor-activity-of-ascending-doses-of-arn-509-in-combination-wi-56864https://curecurrent.com/trials/a-study-of-jnj-80038114-in-participants-with-advanced-stage-prostate-cancer-56865https://curecurrent.com/trials/the-case-of-triple-versus-double-therapy-for-patients-with-high-volume-metastatic-hormone-sensitive-prostate-cancer-56866https://curecurrent.com/trials/pronostic-interest-of-18f-fdg-pet-ct-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcprc-progressing-56867https://curecurrent.com/trials/evaluation-of-psma-pet-and-mpmri-in-high-risk-prostate-cancer-using-histopathologic-validation-56868https://curecurrent.com/trials/optimal-duration-of-hormonal-therapy-for-unfavorable-intermediate-risk-prostate-cancer-patients-6-versus-12-months-56869https://curecurrent.com/trials/oral-epi-7386-in-patients-with-castration-resistant-prostate-cancer-56870https://curecurrent.com/trials/effectiveness-of-localized-prostate-cancer-treatments-56871https://curecurrent.com/trials/epi-7386-in-combination-with-enzalutamide-compared-with-enzalutamide-alone-in-subjects-with-mcrpc-56872https://curecurrent.com/trials/kuopio-lutetium-177-study-in-patients-with-psma-positive-metastatic-prostate-cancer-56873https://curecurrent.com/trials/a-study-of-shr-4394-injection-in-subjects-with-prostate-cancer-56874https://curecurrent.com/trials/preliminary-evaluation-of-uptake-of-68ga-p16-093-in-metastatic-prostate-and-renal-cancer-56875https://curecurrent.com/trials/rectal-spacer-hydrogel-before-radiation-therapy-in-reducing-radiation-dose-to-the-rectum-in-patients-with-prostate-cance-56876https://curecurrent.com/trials/imaging-study-to-investigate-the-safety-and-diagnostic-performance-of-rhpsma-7-3-18f-in-newly-diagnosed-prostate-cancer-56877https://curecurrent.com/trials/s1014-abiraterone-acetate-in-treating-patients-with-prostate-cancer-who-have-undergone-initial-hormone-therapy-56878https://curecurrent.com/trials/177lu-psma-617-and-pembrolizumab-in-treating-patients-with-metastatic-castration-resistant-prostate-cancer-56879https://curecurrent.com/trials/comparison-between-hugo-ras-robotic-platform-and-da-vinci-robotic-platform-56880https://curecurrent.com/trials/the-efficacy-of-mapping-for-cognitive-prostate-biopsy-56881https://curecurrent.com/trials/internet-based-support-for-adjustment-to-prostate-cancer-56882https://curecurrent.com/trials/reduced-length-of-adt-and-arta-with-xrt-in-high-risk-prostate-cancer-relax-a-randomised-trial-56883https://curecurrent.com/trials/cyberknife-dose-escalation-prostate-cancer-trial-56884https://curecurrent.com/trials/dutch-national-randomized-study-psma-pet-ct-as-a-triage-tool-for-pelvic-lymph-node-dissection-in-prostatectomy-patients-56885https://curecurrent.com/trials/cleaning-the-biopsy-needle-in-trus-bx-56886https://curecurrent.com/trials/effect-of-adt-and-arpi-on-bone-loss-of-patients-with-prostate-cancer-56887https://curecurrent.com/trials/prostate-hyperfixation-on-pet-choline-in-patients-with-prostate-cancer-correlation-with-mri-and-pathological-data-loc-ch-56888https://curecurrent.com/trials/radium-223-dichloride-and-abiraterone-acetate-compared-to-placebo-and-abiraterone-acetate-for-men-with-cancer-of-the-pro-56889https://curecurrent.com/trials/diagnostic-performance-of-pet-ct-psma-in-patients-with-non-prostatic-psma-expressing-neoplasms-56890https://curecurrent.com/trials/clinical-application-of-the-j-pet-scanner-prototype-56891https://curecurrent.com/trials/bioprotect-balloon-implant-balloon-system-pivotal-study-bp-007-56892https://curecurrent.com/trials/neoadjuvant-adt-with-tulsa-in-the-treatment-of-intermediate-risk-prostate-cancer-56893https://curecurrent.com/trials/p-psma-101-car-t-cells-in-the-treatment-of-subjects-with-metastatic-castration-resistant-prostate-cancer-mcrpc-and-advan-56894https://curecurrent.com/trials/performance-of-177lu-psma-i-t-for-rlt-in-mcrpc-prospective-multicenter-swiss-registry-study-56895https://curecurrent.com/trials/igf-inhibition-with-xentuzumab-prior-to-radical-prostatectomy-56896https://curecurrent.com/trials/feasibility-of-a-remotely-delivered-resistance-training-program-for-cognitive-function-in-men-living-with-and-beyond-pro-56897https://curecurrent.com/trials/study-on-the-safety-tolerability-and-preliminary-efficacy-of-161tb-nym032-in-patients-with-metastatic-castration-resista-56898https://curecurrent.com/trials/a-phase-i-ii-dose-escalation-study-of-stereotactic-body-radiation-therapy-in-patients-with-localized-prostate-cancer-56899https://curecurrent.com/trials/comparing-rezum-and-urolift-56900https://curecurrent.com/trials/evaluate-safety-whole-body-distribution-and-radiation-dosimetry-in-metastatic-castration-resistant-prostate-cancer-56901https://curecurrent.com/trials/multiparametric-whole-body-mri-a-game-changer-in-metastatic-prostate-cancer-56902https://curecurrent.com/trials/a-study-of-ac176-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-56903https://curecurrent.com/trials/high-impact-training-to-patients-with-prostate-cancer-and-bone-metastases-56904https://curecurrent.com/trials/randomized-trial-of-prostate-only-or-pelvic-rt-in-high-risk-prostate-cancer-56905https://curecurrent.com/trials/biomarkers-of-sulforaphane-broccoli-sprout-extract-in-prostate-cancer-56906https://curecurrent.com/trials/empower-men-to-reduce-weight-and-inhibit-prostate-cancer-progression-56907https://curecurrent.com/trials/antibiotic-prophylaxis-for-hdr-brachytherapy-in-the-treatment-of-prostate-cancer-56908https://curecurrent.com/trials/outcomes-of-simultaneous-transurethral-prostate-and-bladder-tumor-resection-versus-transurethral-bladder-tumor-resection-56909https://curecurrent.com/trials/comparison-of-5-0t-and-3-0t-biparametric-magnetic-resonance-imaging-in-the-diagnosis-of-prostate-cancer-56910https://curecurrent.com/trials/a-diagnostic-prediction-model-for-prostate-cancer-in-patients-with-pi-rads-score-3-56911https://curecurrent.com/trials/clinical-outcomes-of-use-of-olaparib-in-castration-resistant-prostate-cancer-56912https://curecurrent.com/trials/the-addictive-diagnostic-value-of-apparent-diffusion-coefficients-to-bpmri-in-the-diagnosis-of-prostate-cancer-56913https://curecurrent.com/trials/impact-of-18f-psma-1007-imaging-for-primary-staging-of-prostate-cancer-56914https://curecurrent.com/trials/177lu-psma-as-a-systemic-adjuvant-treatment-in-patients-with-high-and-very-high-risk-prostate-cancer-56915https://curecurrent.com/trials/the-evaluation-of-the-effectiveness-safety-and-tolerability-of-treatment-using-a-psma-lu177-in-patients-with-acc-an-open-56916https://curecurrent.com/trials/low-fat-diet-and-fish-oil-in-men-on-active-surveillance-for-prostate-cancer-56917https://curecurrent.com/trials/combination-of-radium-223-and-lutetium-177-psma-i-t-in-men-with-metastatic-castration-resistant-prostate-cancer-56918https://curecurrent.com/trials/additional-treatments-to-the-local-tumour-for-metastatic-prostate-cancer-assessment-of-novel-treatment-algorithms-56919https://curecurrent.com/trials/a-study-of-xmab20717-vudalimab-in-patients-with-selected-advanced-gynecologic-and-genitourinary-malignancies-56920https://curecurrent.com/trials/prostate-assessment-with-restriction-spectrum-imaging-rsi-mri-56921https://curecurrent.com/trials/dual-tracer-theranostic-pet-56922https://curecurrent.com/trials/enzalutamide-in-first-line-androgen-deprivation-therapy-for-metastatic-prostate-cancer-56923https://curecurrent.com/trials/evaluating-the-safety-and-efficacy-of-177lu-lnc1011-injection-in-a-single-center-single-arm-open-study-in-patients-with-56924https://curecurrent.com/trials/abiraterone-acetate-in-asymptomatic-or-mildly-symptomatic-patients-with-metastatic-castration-resistant-prostate-cancer-56925https://curecurrent.com/trials/older-men-s-decision-making-about-active-surveillance-for-prostate-cancer-aim-3-decision-aid-efficacy-testing-56926https://curecurrent.com/trials/a-study-of-abiraterone-acetate-plus-low-dose-prednisone-plus-androgen-deprivation-therapy-adt-versus-adt-alone-in-newly-56927https://curecurrent.com/trials/real-world-study-of-enzalutamide-and-abiraterone-acetate-with-prednisone-tolerability-56928https://curecurrent.com/trials/a-study-of-epi-7386-in-combination-with-abiraterone-acetate-plus-prednisone-or-apalutamide-in-metastatic-castration-resi-56929https://curecurrent.com/trials/prisma-pet-primary-staging-of-prostate-cancer-with-psma-56930https://curecurrent.com/trials/a-post-marketing-surveillance-to-assess-safety-of-abiraterone-acetate-zytiga-in-indian-participants-with-metastatic-cast-56931https://curecurrent.com/trials/a-prospective-compliance-registry-for-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-56932https://curecurrent.com/trials/a-study-of-abiraterone-acetate-in-metastatic-castration-resistant-prostate-cancer-participants-who-responded-poorly-to-t-56933https://curecurrent.com/trials/safety-immunogenicity-of-jnj-64041809-a-live-attenuated-double-deleted-listeria-immunotherapy-in-participants-with-metas-56934https://curecurrent.com/trials/artificial-intelligence-based-platform-integrating-pathologic-imaging-and-molecular-profiles-of-prostate-cancer-56935https://curecurrent.com/trials/psma-pet-to-guide-prostatectomy-56936https://curecurrent.com/trials/mp-3tmri-and-68ga-psma-pet-ct-guided-prostate-biopsy-and-tumor-node-metastasis-tnm-staging-56937https://curecurrent.com/trials/pilot-study-for-black-men-with-prostate-cancer-optimization-of-mental-and-heart-health-the-boom-heart-study-56938https://curecurrent.com/trials/phase-ii-study-of-parp-inhibitor-olaparib-and-iv-ascorbate-in-castration-resistant-prostate-cancer-56939https://curecurrent.com/trials/duration-of-androgen-blockade-combined-with-pelvic-irradiation-in-prostate-cancers-56940https://curecurrent.com/trials/study-of-capivasertib-docetaxel-vs-placebo-docetaxel-as-treatment-for-metastatic-castration-resistant-prostate-cancer-mc-56941https://curecurrent.com/trials/maximal-androgen-depletion-followed-by-randomization-of-maximal-androgen-ablation-with-molecular-targeted-therapies-56942https://curecurrent.com/trials/decision-aids-in-improving-knowledge-in-patients-with-newly-diagnosed-prostate-cancer-56943https://curecurrent.com/trials/study-on-the-role-of-hormonal-treatment-for-two-dosage-levels-of-prostate-radiation-therapy-versus-prostate-radiation-th-56944https://curecurrent.com/trials/the-exploration-of-18f-psma-1007-pet-ct-imaging-in-prostate-cancer-patients-56945https://curecurrent.com/trials/radiation-induced-diarrhoea-during-curative-ebrt-of-prostate-and-rectal-cancer-56946https://curecurrent.com/trials/a-trial-of-shr3162-combined-with-apatinib-mesylate-tablets-or-shr3162-monotherapy-in-patients-with-metastatic-castration-56947https://curecurrent.com/trials/cu-64-psma-i-t-positron-emission-tomography-pet-imaging-of-metastatic-psma-positive-lesions-in-men-with-prostate-cancer-56948https://curecurrent.com/trials/proviz-a-machine-learning-software-to-support-targeting-of-prostate-biopsies-on-mr-images-in-biopsy-naive-patients-56949https://curecurrent.com/trials/fusion-versus-cognitive-mri-targeted-prostatic-biopsy-56950https://curecurrent.com/trials/irofulven-in-ar-targeted-and-docetaxel-pretreated-mcrpc-patients-with-drug-response-predictor-drp-56951https://curecurrent.com/trials/oral-treatment-with-bibf-1120-together-with-docetaxel-and-prednisone-in-patients-with-hormone-refractory-prostate-cancer-56952https://curecurrent.com/trials/imperial-prostate-6-cancer-histology-artificial-intelligence-reliability-study-56953https://curecurrent.com/trials/sthlm3-as-nordcap-a-followup-study-of-men-on-active-surveillance-of-prostate-cancer-56954https://curecurrent.com/trials/a-study-of-evofosfamide-in-combination-with-zalifrelimab-and-balstilimab-56955https://curecurrent.com/trials/efficacy-and-safety-of-adjunctive-use-of-rifaximin-in-preventing-radiotherapy-induced-diarrhea-in-cancer-patients-56956https://curecurrent.com/trials/a-reminder-app-to-optimize-bladder-filling-in-patients-with-prostate-cancer-receiving-hypo-fractionated-radiotherapy-56957https://curecurrent.com/trials/impact-of-using-the-airseal-system-with-ultra-low-pneumoperitoneum-in-patients-undergoing-robot-assisted-radical-prostat-56958https://curecurrent.com/trials/investigation-of-three-biomarkers-for-the-detection-of-prostate-cancer-56959https://curecurrent.com/trials/diagnostic-performance-of-18f-psma-1007-in-the-context-of-biochemical-recurrence-of-prostate-cancer-56960https://curecurrent.com/trials/18f-psma-1007-pet-imaging-to-detect-primary-prostate-cancer-56961https://curecurrent.com/trials/genetic-studies-of-prostate-cancer-aggressiveness-and-prognosis-56962https://curecurrent.com/trials/an-investigational-scan-18f-fluciclovine-pet-ct-for-the-measurement-of-therapeutic-response-in-patients-with-metastatic-56963https://curecurrent.com/trials/stereotactic-body-radiation-therapy-sbrt-for-prostate-cancer-56964https://curecurrent.com/trials/community-interventions-in-non-medical-settings-to-increase-informed-decision-making-for-prostate-cancer-screening-56965https://curecurrent.com/trials/dual-bet-and-cbp-p300-inhibitor-in-patients-with-targeted-advanced-solid-tumors-and-hematological-malignancies-56966https://curecurrent.com/trials/validation-of-a-machine-learning-model-based-on-mr-for-the-prediction-of-prostate-cancer-56967https://curecurrent.com/trials/assessment-of-adc-values-and-radiomics-characteristics-with-a-mri-of-the-prostate-to-identify-tumor-lesions-56968https://curecurrent.com/trials/study-of-177lu-psma-617-in-metastatic-castrate-resistant-prostate-cancer-56969https://curecurrent.com/trials/expanded-access-treatment-with-lu-177-pnt2002-for-adult-patients-with-prostate-specific-membrane-antigen-psma-positive-m-56970https://curecurrent.com/trials/a-non-interventional-study-to-evaluate-time-to-event-and-healthcare-resource-utilisation-for-prostate-cancer-participant-56971https://curecurrent.com/trials/focal-therapy-in-localized-prostate-cancer-a-prospective-registry-56972https://curecurrent.com/trials/biomarkers-for-neoadjuvant-pembrolizumab-in-non-metastatic-prostate-cancer-positive-by-18fdg-pet-scanning-56973https://curecurrent.com/trials/assessment-of-supersonic-imagine-aixplorer-for-the-detection-and-localisation-of-prostate-cancer-foci-56974https://curecurrent.com/trials/study-to-evaluate-a-new-method-to-detect-residual-tumours-during-surgery-for-prostate-cancer-using-confocal-microscopy-56975https://curecurrent.com/trials/phase-iii-study-of-abiraterone-acetate-ii-versus-abiraterone-acetate-in-patients-with-mcrpc-56976https://curecurrent.com/trials/68ga-psma-hbed-pet-ct-in-the-evaluation-of-the-biochemical-relapse-in-patients-with-a-history-of-prostate-cancer-radical-56977https://curecurrent.com/trials/experimental-study-to-evaluate-the-impact-of-18-fluoro-psma-18f-psma-pet-ct-in-the-management-of-patients-with-prostate-56978https://curecurrent.com/trials/physical-function-during-arsi-treatment-56979https://curecurrent.com/trials/dynamic-whole-body-pet-mri-56980https://curecurrent.com/trials/radiometabolic-therapy-rmt-with-177lu-psma-617-in-advanced-castration-resistant-prostate-cancer-crpc-56981https://curecurrent.com/trials/study-on-the-efficacy-and-mechanism-of-mettl3-peptide-inhibitors-in-enhancing-anti-tumor-immune-response-by-reshaping-th-56982https://curecurrent.com/trials/investigation-of-psma-pet-ct-as-an-imaging-biomarker-in-solid-tumors-56983https://curecurrent.com/trials/ibrutinib-as-neoadjuvant-therapy-in-localized-prostate-cancer-56984https://curecurrent.com/trials/cyclophosphamide-and-dexamethasone-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-56985https://curecurrent.com/trials/surgical-treatment-with-or-without-apalutamide-in-subjects-with-high-risk-prostate-cancer-who-are-candidates-for-radical-56986https://curecurrent.com/trials/effectiveness-evaluation-of-a-self-management-program-for-prostate-cancer-survivors-56987https://curecurrent.com/trials/head-to-head-comparison-of-18f-alf-psma-n5-with-18f-f-dcfpyl-pet-ct-in-pca-diagnosis-recurrence-and-metastasis-56988https://curecurrent.com/trials/prostate-mri-and-pylarify-psma-pet-ct-56989https://curecurrent.com/trials/olaparib-for-the-treatment-of-castration-resistant-prostate-adenocarcinoma-56990https://curecurrent.com/trials/a-technique-improves-urinary-continence-in-patients-undergoing-laparoscopic-radical-prostatectomy-56991https://curecurrent.com/trials/a-multicenter-randomized-double-blind-placebo-controlled-phase-iii-study-of-fuzuloparib-combined-with-abiraterone-acetat-56992https://curecurrent.com/trials/intensive-diet-and-exercise-or-standard-of-care-in-improving-physical-function-and-quality-of-life-in-patients-with-pros-56993https://curecurrent.com/trials/preoperative-psma-pet-ct-as-triage-for-eplnd-in-patients-scheduled-for-ralp-prepsma-56994https://curecurrent.com/trials/a-cluster-package-intervention-to-promote-an-evidence-based-use-of-psa-tests-in-general-practice-56995https://curecurrent.com/trials/application-of-18f-psma-pet-ct-imaging-in-prostate-specific-membrane-antigen-positive-tumor-56996https://curecurrent.com/trials/chronic-radiation-induced-bowel-toxicity-study-56997https://curecurrent.com/trials/efficacy-of-repeat-stereotactic-radiation-in-patients-with-intraprostatic-tumor-recurrence-56998https://curecurrent.com/trials/treatment-with-darolutamide-radiation-therapy-for-patients-with-a-castration-resistant-cancer-and-metastases-detected-by-56999https://curecurrent.com/trials/standard-of-care-177lu-psma-617-in-de-novo-mhspc-patients-with-poor-psa-response-peace6-poor-responders-57000